Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40763082	pf-ld	u/l (u/l)	3066	3997	0.20%
40763082	pf-ld	— (—)	259	280	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Malignant neoplasm of bronchus and lung

469

493

8.28

318.86

1.2

1.3

754.56

279.22

u/l

2.68

458

456

Other bacterial diseases

1064

1837

3.95

317.67

1.3

637.71

417.49

u/l

1.52

999

1754

Dyspnoea

1059

2075

3.83

313.21

1.4

1.3

449.08

498.49

u/l

0.32

1013

1951

Other diseases of pleura

2209

695

30.73

307.65

1.4

1.1

404.86

680.29

u/l

1.28

2119

633

All-cause Heart Failure

1000

1380

5.26

307.65

1.4

1.3

342.78

607.84

u/l

2.21

948

1304

Asthma, unspecified (mode)

375

194

14.71

307.65

1.4

1.1

613.23

189.70

u/l

1.58

350

176

Malignant neoplasm of respiratory system and intrathoracic organs

613

556

9.71

307.65

1.3

681.24

293.78

u/l

2.90

597

518

Non-small cell lung cancer, including Hilmo

422

449

9.35

307.65

1.3

658.22

284.71

u/l

3.90

411

415

Bacterial infection, other or unspecified

869

1590

4.72

307.65

1.4

1.3

539.83

409.96

u/l

0.93

819

1518

Pneumonia, organism unspecified

1256

1372

6.54

307.65

1.3

594.22

381.30

u/l

2.10

1193

1308

Asthma, excluding more controls

405

31.30

307.65

1.4

1.0

636.25

246.39

u/l

1.41

382

1173

1195

6.04

307.65

1.3

633.09

370.14

u/l

2.55

1117

1135

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1305

1442

6.28

307.65

1.3

628.62

377.09

u/l

2.67

1237

1367

Heart failure, not strict

1056

1246

5.88

307.65

1.4

1.3

395.87

657.12

u/l

2.16

1003

1187

Malignant neoplasm of bronchus and lung, including Hilmo

542

567

8.39

307.65

1.2

1.3

737.64

304.45

u/l

2.73

526

527

COPD (mode)

404

160

20.32

307.65

1.3

1.1

692.67

148.17

u/l

2.48

384

146

Lung cancer and mesothelioma

650

112

53.28

307.65

1.3

1.1

686.79

160.95

u/l

5.14

633

105

Other pleural conditions

921

171

67.89

307.65

1.5

1.1

397.08

335.16

u/l

0.57

886

160

Pyothorax

339

153

27.58

307.65

1.4

1.3

1870.24

299.41

u/l

6.19

316

148

Pleural effusion

1707

266

85.12

307.65

1.5

1.1

393.39

449.30

u/l

0.22

1646

243

Heart failure, strict

1031

1402

5.33

307.65

1.4

1.3

335.79

607.33

u/l

2.40

977

1325

Suppurative and necrotic conditions of lower respiratory tract

369

188

23.38

307.65

1.4

1.3

1769.20

310.88

u/l

6.29

344

182

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1173

1195

6.04

307.65

1.3

633.09

370.14

u/l

2.55

1117

1135

Other pulmonary diagnosis

648

198

16.58

307.65

1.4

1.1

380.06

187.56

u/l

8.45

619

180

Asthma (only as main-diagnosis), excluding more controls

353

29.90

307.65

1.4

1.0

441.79

246.39

u/l

1.53

326

Asthma, unspecified (mode), excluding more controls

354

39.36

307.65

1.4

1.0

628.36

246.39

u/l

1.18

332

Pneumonias (Asthma/COPD co-morbidities)

1306

1421

6.28

307.65

1.3

629.14

378.61

u/l

2.65

1238

1347

ILD differential diagnosis

634

198

16.21

307.65

1.3

1.1

385.26

187.81

u/l

8.68

607

180

Other medical care

843

1353

5.77

307.65

1.4

1.3

411.26

534.50

u/l

0.98

807

1277

Any death

1014

1247

5.99

307.65

1.3

587.00

418.18

u/l

1.09

971

1184

Influenza and pneumonia

1282

1385

5.98

307.65

1.3

633.53

380.82

u/l

2.61

1214

1318

Heart failure,strict

931

1013

6.68

307.65

1.4

1.3

344.49

662.22

u/l

2.54

885

964

Bacterial infection, other or unspecified

825

1575

4.65

307.65

1.4

1.3

513.95

408.84

u/l

0.71

778

1501

Excluding asthma or asthma-COPD overlap

636

198

16.27

307.65

1.3

1.1

386.14

187.56

u/l

8.78

609

180

COPD differential diagnosis

634

198

16.21

307.65

1.3

1.1

385.26

187.81

u/l

8.68

607

180

All pneumoniae

1307

1417

6.27

307.65

1.3

627.42

379.07

u/l

2.61

1239

1343

Later onset COPD, excluding more controls

296

136

17.30

302.85

1.3

1.1

576.31

153.49

u/l

2.84

278

123

Abnormal findings on diagnostic imaging of lung

791

1814

4.28

293.25

1.4

1.3

552.72

453.17

u/l

0.47

755

1708

Other bacterial diseases

1036

1745

3.81

289.65

1.3

646.30

424.20

u/l

1.48

974

1666

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

897

2105

3.88

286.87

1.4

1.3

537.63

446.41

u/l

0.49

855

1983

Diseases of the respiratory system

459

215

10.80

280.99

1.4

1.1

365.10

228.86

u/l

3.97

441

196

Asthma

428

197

11.47

278.92

1.4

1.1

626.59

187.88

u/l

1.99

405

179

Renal tubulo-interstitial diseases

955

2002

3.60

260.23

1.3

432.49

515.62

u/l

0.46

889

1914

Asthma (only as main-diagnosis)

378

197

11.18

259.75

1.4

1.1

432.10

187.88

u/l

3.69

348

179

Heart failure and antihypertensive medication

416

333

8.40

255.43

1.4

1.2

350.34

760.42

u/l

1.62

397

315

Non-small cell lung cancer

295

304

10.22

254.93

1.3

658.53

277.41

u/l

3.38

288

283

Asthma (mode)

390

198

10.62

247.63

1.4

1.1

510.57

187.81

u/l

3.42

369

180

Persons encountering health services for specific procedures and health care

991

1713

3.50

241.91

1.3

467.59

558.10

u/l

0.56

943

1609

Oxycodone

611

1241

4.56

241.20

1.3

436.00

536.83

u/l

0.63

592

1172

Renal failure

749

1750

3.88

236.87

1.4

1.3

253.19

537.95

u/l

5.44

694

1666

Bacterial Sepsis

697

1504

4.04

232.00

1.4

1.3

391.80

501.65

u/l

0.64

648

1434

Non-ischemic cardiomyopathy

513

802

5.30

230.26

1.4

1.3

464.68

568.27

u/l

0.27

485

763

Non-small cell lung cancer, adenocarcinoma

207

152

14.80

225.86

1.3

801.61

282.06

u/l

3.22

201

144

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

988

2122

3.25

225.41

1.3

397.98

529.00

u/l

1.17

933

2010

All chronic kidney diseases

713

1570

3.78

213.90

1.4

1.3

301.77

527.03

u/l

3.85

666

1499

Implicit bacterial Sepsis

633

1424

4.03

211.79

1.4

1.3

365.73

479.06

u/l

0.63

589

1358

Bacterial pneumoniae

507

954

4.77

210.69

1.4

1.3

627.93

360.25

u/l

1.50

478

910

Implicit bacterial Sepsis

657

1487

3.90

208.54

1.4

1.3

370.00

497.50

u/l

0.75

610

1419

Bacterial pneumonia, not elsewhere classified

491

919

4.79

205.03

1.4

1.3

619.01

365.17

u/l

1.33

465

878

Heart failure and bmi 25plus

502

691

5.03

199.11

1.4

1.3

463.74

691.24

u/l

0.66

476

649

Implicit Sepsis

812

1857

3.34

198.89

1.4

1.3

395.01

492.61

u/l

0.64

760

1771

All kidney diseases

903

1967

3.17

197.92

1.3

455.95

531.46

u/l

0.39

847

1879

Septicaemia

580

1388

3.99

194.90

1.4

1.3

605.25

390.80

u/l

1.00

537

1325

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

363

637

5.79

193.54

1.3

481.00

344.08

u/l

1.28

344

600

Liquid cancers, helper endpoint

463

857

4.80

193.14

1.3

320.87

403.81

u/l

0.67

429

797

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

305

464

6.79

191.24

1.3

449.72

306.13

u/l

3.47

286

437

Explicit Sepsis

586

1470

3.79

183.66

1.4

1.3

599.68

477.61

u/l

0.43

543

1401

Heart failure and coronary heart disease

679

1354

3.64

183.30

1.4

1.3

209.79

593.95

u/l

6.50

642

1289

Other heart diseases, wide

669

1093

3.77

182.92

1.4

1.2

331.63

696.02

u/l

6.55

640

1036

COPD/asthma/ILD related infections

816

1195

3.45

182.23

1.4

1.3

538.69

370.14

u/l

1.09

775

1135

COPD/asthma related infections

816

1195

3.45

182.23

1.4

1.3

538.69

370.14

u/l

1.09

775

1135

Abnormalities of breathing

781

1353

3.38

179.61

1.4

1.2

454.85

547.94

u/l

0.56

738

1279

Implicit Sepsis

798

1889

3.12

174.16

1.4

1.3

394.23

498.38

u/l

0.69

745

1803

Chronic kidney disease

517

1314

3.96

173.58

1.4

1.3

235.02

507.59

u/l

4.11

480

1250

Malignant neoplasm

685

1142

3.58

172.11

1.3

471.82

430.03

u/l

0.24

655

1063

Other septicaemia

519

1303

3.91

171.04

1.4

1.3

595.91

379.68

u/l

0.89

482

1241

Non-rheumatic valve diseases

491

833

4.32

168.93

1.4

1.3

268.85

684.70

u/l

6.89

465

788

Valvular heart disease excluding rheumatic fever

491

835

4.31

168.62

1.4

1.3

269.13

684.02

u/l

6.88

465

789

Non-small cell lung cancer, adenocarcinoma, helper endpoint

207

240

9.34

166.00

1.3

801.61

347.89

u/l

2.58

201

230

Acute renal failure

387

840

4.75

165.26

1.4

1.3

244.05

528.96

u/l

2.42

360

801

Other heart diseases

338

361

6.17

163.45

1.4

1.2

356.21

818.77

u/l

3.13

326

342

Malignant neoplasm, wide definition for exclusion

676

1152

3.47

162.03

1.3

409.79

432.38

u/l

0.16

645

1073

Dialysis, with operation codes

255

386

6.88

161.09

1.4

1.3

240.40

348.29

u/l

2.11

240

369

Nephropathy related operations

252

396

6.64

153.68

1.4

1.3

225.71

362.87

u/l

3.40

237

378

Solid cancers, helper endpoint

646

1135

3.39

150.02

1.3

454.46

431.57

u/l

0.13

618

1056

Non-invasive ventilation

253

347

6.62

149.56

1.5

1.3

601.47

545.85

u/l

0.08

230

332

Condition for Implicit Sepsis (Organ dysfunction codes)

762

1873

2.90

145.42

1.3

397.41

508.52

u/l

0.72

714

1788

Fever of other and unknown origin

568

1541

3.32

144.84

1.4

1.3

523.76

534.72

u/l

0.03

528

1465

Any event in cancer register

686

1281

3.18

144.44

1.3

431.05

434.37

u/l

0.02

657

1191

First line medication for Crohn's disease

878

1768

2.70

136.46

1.4

1.3

535.39

510.00

u/l

0.10

832

1664

Any gastric operation

501

641

3.94

134.28

1.3

364.29

632.37

u/l

1.57

478

603

GASTRO-related operations

501

641

3.94

134.28

1.3

364.29

632.37

u/l

1.57

478

603

Condition for Implicit Sepsis (Organ dysfunction codes)

737

1813

2.83

133.75

1.3

423.88

517.39

u/l

0.51

695

1729

Atrial fibrillation and flutter

277

303

6.00

130.11

1.4

1.2

388.04

762.46

u/l

2.11

268

285

Atrial fibrillation and flutter with reimbursement

258

261

6.39

126.70

1.3

1.2

367.67

742.66

u/l

1.86

248

245

Aplastic and other anaemias

583

1879

2.94

121.86

1.3

396.20

471.07

u/l

0.36

550

1776

Bacterial pneumonia (organism specified)

538

1627

3.04

119.03

1.4

1.3

612.51

410.76

u/l

1.06

507

1542

Erysipelas

625

1705

2.82

116.57

1.3

621.13

424.51

u/l

0.72

583

1630

Diseases of arteries, arterioles and capillaries (FINNGEN)

224

254

6.19

111.56

1.3

1.2

277.13

753.46

u/l

3.25

215

238

Care involving dialysis

152

196

8.08

110.98

1.4

1.3

180.33

323.05

u/l

3.64

141

186

Oral corticosteroids

861

2131

2.41

110.23

1.4

1.3

514.33

490.58

u/l

0.10

812

2017

Other anaemias

537

1801

2.88

108.77

1.3

416.44

475.37

u/l

0.24

507

1704

Other and unspecified anaemias

533

1789

2.88

108.38

1.3

416.79

474.65

u/l

0.24

503

1692

Cardiomyopathy

216

408

5.41

108.31

1.4

1.2

407.03

745.05

u/l

0.76

203

387

Ascites

160

228

7.34

107.14

1.3

330.63

329.09

u/l

0.01

150

216

ILD medications: prednisolone, methylprednisolone, prednisone

846

1979

2.41

105.90

1.4

1.3

530.02

494.02

u/l

0.15

802

1870

Secondary uncertain malignant neoplasm

182

332

5.63

95.02

1.3

372.31

285.71

u/l

1.10

172

310

ILD medications

833

1982

2.29

93.02

1.4

1.3

533.34

494.88

u/l

0.16

785

1873

Cardiac arrhythmias

355

651

3.57

92.35

1.4

1.3

363.01

691.96

u/l

3.26

341

618

Erysipelas

503

1645

2.73

91.58

1.3

701.44

419.76

u/l

0.88

467

1571

Inflammatory bowel disease treatment related agents

851

2135

2.24

91.24

1.4

1.3

514.86

491.07

u/l

0.10

805

2020

COPD

524

1648

2.64

86.91

1.3

626.14

443.74

u/l

0.66

497

1558

Haemorrhage from respiratory passages

367

1075

3.12

84.97

1.4

1.2

323.45

529.89

u/l

1.88

351

1018

Certain infectious and parasitic diseases

654

1328

2.48

84.46

1.4

1.3

347.13

433.47

u/l

1.73

621

1266

Cerebrovascular diseases (FINNGEN)

209

305

4.89

83.34

1.3

1.2

384.05

759.75

u/l

2.38

202

288

Other disorders of fluid, electrolyte and acid-base balance

363

1139

3.08

83.30

1.3

561.50

499.76

u/l

0.14

348

1085

Extracorporeal dialysis

127

187

7.12

82.67

1.5

1.3

164.07

340.13

u/l

5.24

116

180

Other chronic obstructive pulmonary disease

504

1615

2.61

82.04

1.3

634.18

443.92

u/l

0.67

478

1528

Continuous positive airway pressure

181

301

5.14

81.22

1.3

963.01

562.44

u/l

0.47

169

287

Acute tubulo-interstitial nephritis

511

1764

2.52

78.94

1.3

563.17

509.66

u/l

0.14

479

1692

Implicit viral Sepsis

309

965

3.25

78.50

1.4

1.3

301.16

478.86

u/l

1.56

288

918

Covid-19 confirmed case

392

1414

2.81

77.20

1.3

484.25

485.01

u/l

0.00

377

1328

Other arrhythmias

390

1017

2.91

77.14

1.3

1.2

364.08

675.48

u/l

3.23

371

966

Codes for special purposes

464

1832

2.55

75.87

1.3

471.76

478.59

u/l

0.03

445

1729

Provisional assignment of new diseases of uncertain etiology

463

1828

2.55

75.71

1.3

472.61

478.83

u/l

0.02

444

1726

Cardiomyopathy (excluding other)

149

279

5.46

75.60

1.3

506.24

713.44

u/l

0.26

142

260

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

172

365

4.81

75.56

1.3

370.77

296.65

u/l

0.81

160

343

Non-allergic asthma (mode)

9.65

75.06

1.4

1.1

717.85

148.83

u/l

1.16

Non-Hodgkin lymphoma, all, including Hilmo

162

330

5.02

74.76

1.3

336.00

291.35

u/l

0.41

149

310

COPD, hospital admissions

513

1785

2.46

74.61

1.3

1.4

632.49

455.82

u/l

0.61

486

1687

Other chronic obstructive pulmonary disease, including avohilmo

559

1973

2.37

74.46

1.3

648.56

447.90

u/l

0.80

528

1866

Diseases of arteries, arterioles and capillaries

642

2129

2.25

74.17

1.3

318.88

516.55

u/l

2.86

603

2021

COPD, early/later onset

515

1798

2.45

73.81

1.3

1.4

629.86

456.17

u/l

0.60

488

1700

Cardiomyopathies, Primary/intrinsic

143

268

5.45

72.51

1.3

516.83

726.19

u/l

0.25

136

253

Implicit viral Sepsis

233

641

3.70

72.35

1.4

1.3

288.56

374.90

u/l

1.32

218

608

Viral Sepsis

233

641

3.70

72.35

1.4

1.3

288.56

374.90

u/l

1.32

218

608

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

682

2042

2.19

71.91

1.4

1.3

357.42

570.45

u/l

2.17

642

1938

Hypertensive heart and/or renal disease

309

729

3.21

71.32

1.4

1.3

485.56

677.07

u/l

0.38

290

699

Cardiovascular diseases (excluding rheumatic etc)

252

375

3.88

70.53

1.4

1.2

378.82

813.30

u/l

3.33

239

355

Primary_lymphoid and hematopoietic malignant neoplasms

296

964

3.13

70.35

1.3

335.54

497.21

u/l

1.14

275

911

All influenza

207

541

3.87

69.05

1.4

1.3

647.10

348.09

u/l

0.44

188

516

COPD, hospital admissions 3, with asthma pneumonia sepsis

369

1151

2.79

68.79

1.3

668.26

389.78

u/l

0.82

348

1087

Any reimbursement code in KELA

223

254

4.42

68.74

1.4

1.2

386.19

797.07

u/l

1.48

213

239

Malaise and fatigue

442

1410

2.55

68.66

1.3

479.38

533.16

u/l

0.20

412

1339

Valvular operations

157

335

4.78

68.51

1.5

1.3

234.31

733.09

u/l

3.69

149

315

COPD, hospital admission 2, with asthma infections

402

1319

2.65

68.38

1.3

642.51

402.19

u/l

0.75

380

1246

Conduction disorders

257

615

3.43

67.55

1.4

1.3

248.63

648.89

u/l

6.02

247

589

COPD related to multimorbidity

466

1624

2.46

67.52

1.3

639.55

430.09

u/l

0.68

441

1531

Asthma-related pneumonia

384

1479

2.62

66.28

1.3

675.99

408.42

u/l

0.79

354

1395

Other CVD (FINNGEN)

124

155

6.32

66.25

1.3

1.2

973.18

609.96

u/l

0.36

116

146

Asthma-related pneumonia or sepsis

384

1480

2.62

66.18

1.3

675.99

408.26

u/l

0.79

354

1396

Asthma, hospital admissions 3, pneumonia

384

1480

2.62

66.18

1.3

675.99

408.26

u/l

0.79

354

1396

Neoplasms

389

730

2.84

66.13

1.4

1.3

390.72

562.09

u/l

1.31

368

687

Bleeding

672

2281

2.11

66.10

1.4

1.3

458.48

496.95

u/l

0.16

637

2154

General symptoms and signs

698

1644

2.14

64.98

1.3

410.23

529.56

u/l

1.05

657

1565

Infections, IBD-co-morbidities

169

259

4.73

64.97

1.4

1.2

348.95

647.12

u/l

1.40

157

251

Glomerular diseases

225

651

3.53

64.90

1.4

1.3

288.56

352.69

u/l

0.85

212

621

Hypertensive diseases (excluding secondary)

235

360

3.81

64.53

1.4

1.2

407.50

818.54

u/l

2.79

223

341

Opioids

618

1449

2.23

64.11

1.3

393.49

543.96

u/l

1.44

587

1364

ILD medications: immunosuppressive drugs

427

1625

2.46

63.80

1.4

1.3

454.66

515.66

u/l

0.47

409

1540

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

214

345

3.94

63.31

1.4

1.2

742.58

732.71

u/l

0.01

200

327

Polyarthropathies

556

1629

2.25

62.51

1.4

1.3

418.24

522.57

u/l

0.88

521

1552

Presence of cardiac and vascular implants and grafts

487

1558

2.35

62.39

1.4

1.3

235.49

568.28

u/l

6.18

466

1481

Metabolic disorders

663

1947

2.09

61.47

1.4

1.3

440.97

521.50

u/l

0.47

631

1837

Pulmonary heart disease, diseases of pulmonary circulation

350

1342

2.64

61.33

1.3

374.72

481.93

u/l

0.85

329

1270

Diabetic nephropathy, excluding more controls

193

420

3.87

60.19

1.3

264.88

453.80

u/l

1.40

179

399

Tramadol

525

1425

2.28

60.12

1.3

387.27

543.52

u/l

1.39

491

1342

Glomerular disorders in diseases classified elsewhere

167

416

4.12

60.01

1.4

1.3

285.43

328.61

u/l

0.39

157

398

Complications of surgical and medical care, not elsewhere classified

717

2484

1.99

59.76

1.4

1.3

375.89

509.87

u/l

1.05

683

2344

ILD, hospital admissions 3, with pneumonia sepsis

121

245

5.08

56.44

1.3

519.04

300.31

u/l

2.43

113

231

Iron deficiency anaemia

395

1643

2.39

56.17

1.4

1.3

405.18

477.47

u/l

0.23

369

1560

Secondary and unspecified malignant neoplasm of lymph nodes

103

182

5.80

55.79

1.4

1.3

358.41

290.33

u/l

0.50

172

ILD, hospital admission 2, with pulmonary infections

125

266

4.81

54.91

1.3

517.95

320.23

u/l

2.11

116

255

malignant neoplasm of female genital organs

118

238

5.00

54.57

1.2

1.3

447.65

252.35

u/l

3.50

113

219

Symptoms and signs involving the circulatory and respiratory systems

574

1354

2.13

53.36

1.4

1.2

357.72

548.95

u/l

2.29

545

1280

Percutaneous Coronary Intervention

570

1680

2.09

53.21

1.4

1.3

358.71

605.06

u/l

2.08

542

1593

Hypertension, essential

457

1130

2.30

52.58

1.4

1.3

384.48

672.43

u/l

3.41

432

1078

Pulmonary embolism

307

1193

2.61

52.44

1.3

403.64

481.51

u/l

0.48

288

1127

Other respiratory disorders and diseases

255

904

2.87

52.26

1.5

1.3

309.45

389.86

u/l

0.84

235

854

Other diseases of the respiratory system

255

904

2.87

52.26

1.5

1.3

309.45

389.86

u/l

0.84

235

854

Pulmonary heart disease

307

1209

2.57

51.04

1.3

403.64

476.67

u/l

0.45

288

1142

Emergency coronary revascularization (for ACS)

633

1959

1.98

50.60

1.4

1.3

350.72

564.92

u/l

2.01

601

1857

Peripheral artery disease

464

1723

2.17

49.99

1.3

1.4

317.84

536.57

u/l

2.31

430

1639

Hypertensive Heart Disease

255

702

2.88

49.97

1.3

548.96

630.73

u/l

0.12

240

674

Chronic lower respiratory diseases

770

2223

1.85

49.36

1.3

618.19

460.34

u/l

0.71

732

2102

Caries of dentine

219

715

3.02

49.14

1.4

1.3

926.09

414.68

u/l

0.80

209

678

Malignant neoplasm of breast, HER2-negative, including Hilmo

201

385

3.40

49.09

1.3

400.65

319.34

u/l

0.37

192

354

Malignant neoplasm of breast, including Hilmo

201

385

3.40

49.09

1.3

400.65

319.34

u/l

0.37

192

354

Coronary revascularization (ANGIO or CABG)

557

1680

2.04

48.83

1.4

1.3

347.71

605.06

u/l

2.20

530

1593

Venous thromboembolism

477

2224

2.09

48.72

1.3

491.49

473.68

u/l

0.08

444

2107

Malignant neoplasm of breast, HER2-negative

198

383

3.40

48.59

1.3

393.50

319.63

u/l

0.32

189

352

DVT of lower extremities and pulmonary embolism

396

1777

2.24

48.55

1.3

450.27

480.80

u/l

0.16

369

1685

Malignant neoplasm of breast

198

384

3.38

48.13

1.3

395.32

319.18

u/l

0.33

189

353

Nutritional anaemias

438

1983

2.15

48.06

1.4

1.3

384.40

469.23

u/l

0.32

409

1881

Insulin medication

480

1952

2.08

47.53

1.4

1.3

314.89

539.09

u/l

2.88

453

1848

Hypertensive diseases

444

1133

2.22

47.24

1.4

1.3

372.08

671.28

u/l

3.67

422

1081

Secondary hypertension

103

7.02

47.09

1.2

257.12

599.44

u/l

3.56

Hypertension

443

1133

2.22

46.86

1.4

1.3

372.15

671.28

u/l

3.66

421

1081

Cardiovascular diseases

203

322

3.40

46.48

1.3

1.2

381.79

843.17

u/l

2.90

193

304

Pacemaker

374

1604

2.26

46.45

1.4

1.3

222.05

471.98

u/l

4.66

358

1505

Dental caries

230

790

2.83

45.95

1.4

1.3

891.36

423.29

u/l

0.75

220

748

Certain infectious and parasitic diseases

462

1062

2.19

45.83

1.4

1.3

338.88

445.23

u/l

1.99

441

1010

Hypo-osmolality and hyponatraemia

194

633

3.10

45.65

1.3

598.88

399.92

u/l

0.58

184

597

Parasetamol

443

1017

2.22

45.45

1.3

369.16

486.47

u/l

1.39

422

969

Codeine

536

1438

2.03

45.25

1.3

476.70

541.60

u/l

0.24

507

1356

Type 2 diabetes, wide definition

578

1908

1.95

45.15

1.3

318.79

537.38

u/l

3.73

549

1810

Hard cardiovascular diseases

540

1618

2.00

44.61

1.4

1.3

287.71

624.63

u/l

6.13

516

1536

Depression medications

7.48

44.14

1.5

1.3

430.09

671.62

u/l

1.43

Other and unspecified iron deficiency

300

1251

2.42

44.08

1.4

1.3

429.41

429.12

u/l

0.00

283

1183

Complications of procedures, not elsewhere classified

560

2443

1.91

43.25

1.4

1.3

400.91

509.40

u/l

0.60

532

2306

Autoimmune diseases excluding thyroid diseases, strict definition

668

1990

1.85

42.81

1.4

1.3

428.35

535.86

u/l

0.94

630

1883

Gout

317

1197

2.36

42.77

1.4

1.3

294.19

569.44

u/l

2.70

299

1132

Malignant neoplasm of breast, ER-positive, including Hilmo

162

365

3.45

42.75

1.3

429.17

321.35

u/l

0.41

154

335

Complications of medical and surgical care

527

2531

1.93

42.67

1.4

1.3

376.25

502.84

u/l

0.70

501

2392

Major coronary heart disease event

578

1833

1.91

42.21

1.4

1.3

283.57

580.60

u/l

6.13

552

1740

Malignant neoplasm of breast, HER-positive

159

363

3.44

41.96

1.3

429.31

320.51

u/l

0.41

151

333

Autoimmune diseases excluding thyroid diseases

683

2057

1.82

41.79

1.4

1.3

424.79

526.44

u/l

0.90

644

1947

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

321

923

2.38

41.71

1.3

453.53

405.35

u/l

0.14

304

855

Atherosclerosis, excluding cerebral and coronary sclerosis

431

1662

2.08

41.61

1.3

310.00

522.21

u/l

2.15

398

1582

Asthma-related infections

427

2056

2.05

41.61

1.3

635.93

448.31

u/l

0.56

394

1948

Asthma, hospital admission 2, infections

427

2056

2.05

41.61

1.3

635.93

448.31

u/l

0.56

394

1948

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

129

228

4.08

41.41

1.3

1.2

477.26

653.14

u/l

0.52

119

220

Later onset COPD

342

1220

2.27

41.00

1.3

542.05

373.35

u/l

0.81

322

1146

Malignant neoplasm of skin

323

950

2.35

40.95

1.3

486.38

406.07

u/l

0.26

308

881

Ischemic heart diseases

543

1698

1.93

40.70

1.4

1.3

289.96

603.43

u/l

6.02

514

1610

Malignant neoplasm of digestive organs

271

870

2.48

40.03

1.3

687.72

396.79

u/l

0.51

254

808

STROKE

357

1098

2.22

39.97

1.3

348.63

649.76

u/l

3.24

341

1044

Diabetic nephropathy

196

691

2.86

39.74

1.3

262.15

463.07

u/l

1.48

182

656

Enterocolitis due to Clostridium difficile

136

394

3.52

39.40

1.4

1.3

253.67

290.05

u/l

0.55

121

377

Calcific aortic valvular stenosis, diagnosis (helper)

336

1501

2.20

39.05

1.4

1.3

337.78

448.70

u/l

0.60

311

1419

Operations 2 for CAVS

336

1501

2.20

39.05

1.4

1.3

337.78

448.70

u/l

0.60

311

1419

Calcific aortic valvular stenosis, operated

336

1502

2.20

38.99

1.4

1.3

337.78

448.70

u/l

0.60

311

1419

Calcific aortic valvular stenosis

336

1502

2.20

38.99

1.4

1.3

337.78

448.70

u/l

0.60

311

1419

Coronary atherosclerosis

484

1565

1.97

38.85

1.4

1.3

284.95

605.20

u/l

5.50

460

1483

Other diseases of blood and blood-forming organs, wide

203

747

2.75

38.84

1.3

685.88

352.29

u/l

0.74

192

707

Oedema, not elsewhere classified

259

1059

2.43

38.58

1.4

1.3

344.47

537.52

u/l

1.09

244

1005

Calcific aortic valvular stenosis, including rheumatic fever

336

1507

2.19

38.57

1.4

1.3

337.78

447.41

u/l

0.59

311

1425

Care involving use of rehabilitation procedures

371

1632

2.10

38.51

1.3

487.46

543.25

u/l

0.16

347

1533

Pain in throat and chest

451

1348

2.02

38.37

1.4

1.2

528.14

548.46

u/l

0.05

420

1274

Unspecified kidney failure

134

392

3.49

38.29

1.3

252.43

428.27

u/l

1.01

129

373

Gout, FINNGEN

317

1438

2.23

38.25

1.4

1.3

294.19

558.86

u/l

2.91

299

1362

Other malignant neoplasms of skin (=non-melanoma skin cancer)

302

890

2.34

38.22

1.3

476.39

399.16

u/l

0.23

287

826

Insulin, fast-acting

292

1284

2.29

38.06

1.4

1.3

234.47

500.51

u/l

4.08

274

1216

Basal cell carcinoma, including avohilmo

300

891

2.34

37.77

1.3

487.55

399.56

u/l

0.26

283

828

Diseases of oesophagus, stomach and duodenum

675

2315

1.75

37.24

1.4

1.3

564.70

486.34

u/l

0.31

632

2204

Cardiomyopathy, other and unspecified

156

5.10

36.94

1.5

1.3

798.24

487.71

u/l

0.21

145

Insulin, combination of fast acting with intermediate-acting or long-acting

480

2336

1.89

36.76

1.4

1.3

314.89

511.36

u/l

2.65

453

2208

Basal cell carcinoma

293

878

2.33

36.59

1.3

486.11

390.22

u/l

0.28

277

815

Adjustment and management of implanted device

187

686

2.76

36.07

1.4

1.3

225.28

532.09

u/l

1.91

181

644

Other bacterial intestinal infections

178

641

2.81

35.56

1.3

311.25

410.33

u/l

0.76

160

600

Hernia of abdominal wall, postoperative

114

314

3.66

35.50

1.3

1.2

308.67

816.67

u/l

1.48

107

298

Insulin, intermediate and long-acting

431

2191

1.92

35.26

1.4

1.3

259.71

518.87

u/l

5.78

406

2073

Other disorders of skin and subcutaneous tissue

504

2453

1.84

35.15

1.3

410.30

482.70

u/l

0.48

467

2329

Insulin, fast-acting or short human

294

1343

2.21

35.00

1.4

1.3

239.56

508.96

u/l

4.27

276

1270

Myocardial infarction

399

1406

2.01

34.81

1.3

317.47

605.55

u/l

3.74

378

1332

Disorders of lipoprotein metabolism and other lipidaemias

550

1881

1.82

34.78

1.4

1.3

398.84

506.11

u/l

0.88

522

1776

Diffuse large B-cell lymphoma, helper endpoint

102

6.06

33.98

1.3

468.38

294.04

u/l

0.96

Diffuse large B-cell lymphoma

102

6.06

33.98

1.3

468.38

294.04

u/l

0.96

Diffuse large B-cell lymphoma, including Hilmo

102

6.06

33.98

1.3

468.38

294.04

u/l

0.96

Enlarged lymph nodes

135

427

3.20

33.92

1.4

1.3

359.34

399.24

u/l

0.31

127

406

Ulcer of lower limb, not elsewhere classified

169

609

2.82

33.84

1.3

370.13

338.91

u/l

0.10

160

578

Intestinal infectious diseases

590

2578

1.74

33.77

1.3

384.35

509.73

u/l

1.73

549

2444

Diabetes, varying definitions

597

2009

1.75

32.79

1.3

305.88

549.44

u/l

5.42

570

1901

Diabetes mellitus

597

2007

1.75

32.55

1.3

306.02

549.77

u/l

5.42

571

1899

Major coronary heart disease event excluding revascularizations

456

1630

1.88

32.23

1.4

1.3

303.23

571.23

u/l

4.23

431

1546

Streptococcal septicaemia

102

281

3.70

31.96

1.2

1.3

963.65

327.69

u/l

0.71

267

Explicit bacterial Sepsis

113

335

3.43

31.63

1.2

1.3

883.89

358.26

u/l

0.64

104

322

Endocrine, nutritional and metabolic diseases

407

1045

1.98

31.59

1.3

360.76

617.31

u/l

2.52

391

993

Bacterial intestinal infections, IBD co-morbidities

175

665

2.67

31.56

1.4

1.3

310.65

392.78

u/l

0.61

157

626

Dipeptidyl peptidase 4 (DPP-4) inhibitors

451

1971

1.85

31.39

1.4

1.3

261.50

518.93

u/l

5.41

421

1870

Other bacterial intestinal infections

196

791

2.50

31.19

1.3

320.12

399.31

u/l

0.68

176

739

Diarrhoea and gastroenteritis of presumed infectious origin

438

2153

1.84

31.03

1.3

399.75

539.10

u/l

1.51

410

2037

Pure hypercholesterolaemia

503

1840

1.79

30.77

1.3

442.92

503.71

u/l

0.36

481

1737

Gout, idiopatic and unspecified

263

1216

2.19

30.65

1.4

1.3

303.88

532.38

u/l

2.20

249

1158

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

154

248

3.13

30.51

1.3

1.2

370.50

405.96

u/l

0.35

146

234

COPD-related respiratory insufficiency

148

531

2.84

29.99

1.3

720.57

401.84

u/l

0.33

139

502

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

568

1993

1.72

29.91

1.3

335.35

551.49

u/l

3.27

541

1886

COPD, hospital admissions 1, only main diagnosis

341

1486

1.98

29.80

1.3

574.16

440.35

u/l

0.31

322

1406

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

159

594

2.72

29.77

1.4

1.3

809.16

347.24

u/l

0.74

147

569

Non-follicular lymphoma

117

369

3.24

29.77

1.4

1.3

351.44

322.70

u/l

0.20

106

352

Type 2 diabetes

581

1996

1.71

29.36

1.3

339.53

550.31

u/l

3.21

554

1888

Diabetes, insulin treatment (Kela reimbursement)

623

2261

1.67

29.30

1.3

347.36

540.87

u/l

2.64

595

2138

Amputation

127

429

3.02

28.71

1.4

1.3

407.86

416.31

u/l

0.02

118

407

Iron deficiency anaemia secondary to blood loss (chronic)

151

565

2.71

28.15

1.4

1.3

285.33

401.02

u/l

0.74

140

534

Type 1 diabetes, wide definition, subgroup 1

140

503

2.80

28.07

1.3

223.62

454.53

u/l

8.78

130

480

Diseases of the digestive system

369

1974

1.87

28.04

1.4

1.3

515.79

475.62

u/l

0.09

346

1867

Agranulocytosis

106

327

3.29

27.91

1.2

1.4

890.40

333.73

u/l

0.65

315

Diseases of liver

255

1211

2.12

27.69

1.4

1.3

653.22

507.91

u/l

0.28

237

1151

Other respiratory diseases principally affecting the interstitium

194

825

2.39

27.68

1.3

424.27

368.80

u/l

0.38

182

780

Cardiodefibrillation

330

1719

1.93

27.55

1.4

1.3

352.18

530.72

u/l

1.12

314

1634

680

2190

1.61

26.79

1.3

386.40

474.33

u/l

1.22

638

2080

Type 1 diabetes

169

685

2.48

26.60

1.3

238.62

627.90

u/l

2.92

161

648

GI-bleeding

293

1489

1.99

26.48

1.4

1.3

571.83

451.68

u/l

0.26

275

1407

Peripheral arterial reconstruction

199

874

2.31

26.41

1.4

1.3

374.05

403.79

u/l

0.10

183

827

Other acute lower respiratory infections

368

1917

1.84

26.33

1.3

505.37

468.06

u/l

0.15

342

1814

Gout, unspecified

216

983

2.23

26.30

1.4

1.3

308.06

535.67

u/l

1.65

205

933

Cerebrovascular diseases

539

2278

1.67

26.18

1.3

329.54

514.99

u/l

3.06

509

2163

Asthma/COPD (KELA code 203)

539

2221

1.67

26.06

1.4

1.3

657.96

448.97

u/l

0.70

509

2100

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

413

2326

1.76

25.75

1.4

1.3

406.84

501.79

u/l

0.36

393

2202

Disorders of choroid and retina

561

2438

1.64

25.60

1.3

440.44

489.89

u/l

0.20

535

2305

Ischaemic heart disease, wide definition

503

1843

1.70

25.35

1.4

1.3

310.45

560.76

u/l

4.41

478

1743

Persons encountering health services in other circumstances, wide

705

2318

1.57

25.13

1.4

1.3

511.57

483.76

u/l

0.11

672

2188

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

118

4.86

25.11

1.4

1.3

171.01

286.66

u/l

1.79

113

Diabetes medication

595

2181

1.62

25.05

1.3

351.24

546.11

u/l

2.76

567

2064

Bronchitis

640

2546

1.59

24.97

1.3

412.99

498.78

u/l

0.95

600

2411

Myocardial infarction, strict

354

1363

1.86

24.94

1.3

418.21

612.43

u/l

0.82

335

1291

Other diseases of the digestive system

288

1487

1.95

24.90

1.4

1.3

576.84

454.34

u/l

0.26

270

1404

Abnormal findings on examination of blood, without diagnosis

376

1931

1.80

24.88

1.3

377.71

514.00

u/l

1.29

353

1829

Infections of the skin and subcutaneous tissue

346

1878

1.83

24.73

1.3

561.31

532.66

u/l

0.07

327

1779

Symptoms and signs involving the urinary system

513

2372

1.65

24.45

1.4

1.3

541.50

479.43

u/l

0.23

477

2249

Syncope and collapse

307

1382

1.91

24.41

1.3

449.74

528.29

u/l

0.19

287

1310

Fall on same level

635

2185

1.59

24.28

1.3

622.99

465.84

u/l

0.58

597

2073

Gout, strict definition

196

888

2.24

24.19

1.4

1.3

238.57

503.68

u/l

2.22

184

842

Used for control exclusion in common control thyroid runs

607

1908

1.61

24.05

1.4

1.3

476.63

542.70

u/l

0.28

578

1802

Other CVD

199

913

2.21

23.77

1.3

693.80

382.16

u/l

0.55

188

857

Type 1 diabetes, wide definition

144

572

2.53

23.74

1.3

231.33

433.10

u/l

7.14

134

540

Antihypertensive medication - note that there are other indications

196

443

2.35

23.68

1.4

1.2

368.19

766.77

u/l

3.17

187

417

Autoimmune diseases

639

2061

1.58

23.45

1.4

1.3

472.07

526.22

u/l

0.23

606

1951

Need for other prophylactic measures

150

4.22

23.39

1.3

473.54

333.11

u/l

0.67

144

Nonischemic cardiomyopathy

100

332

3.06

23.33

1.3

791.58

367.94

u/l

0.41

317

Volume depletion

103

349

3.00

23.23

1.4

1.3

280.03

429.03

u/l

0.65

329

Disorders of lens

451

1661

1.70

23.05

1.4

1.3

297.27

502.77

u/l

4.70

429

1575

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

280

3.24

22.83

1.4

367.69

315.77

u/l

0.34

265

Hyperlipidaemia, other/unspecified

305

1514

1.87

22.82

1.4

1.3

257.09

483.33

u/l

3.78

287

1434

Gastroduodenal ulcer

243

1218

2.01

22.77

1.3

489.92

450.68

u/l

0.07

228

1162

Diabetic retinopathy, excluding more controls

194

477

2.30

22.55

1.2

1.3

479.58

443.87

u/l

0.05

185

455

Other retinal disorders

470

2230

1.65

22.28

1.3

312.40

487.12

u/l

2.36

445

2108

Early onset COPD

180

819

2.22

21.97

1.3

778.73

452.36

u/l

0.44

173

778

Substance abuse, excluding more controls

363

1772

1.75

21.93

1.3

868.77

465.97

u/l

1.43

339

1686

387

2049

1.71

21.76

1.3

727.46

484.53

u/l

0.83

358

1947

Peripheral artery operations in Hilmo

138

563

2.48

21.68

1.3

439.44

441.75

u/l

0.00

129

534

Codeine or tramadol medication

658

2351

1.54

21.67

1.3

454.37

505.69

u/l

0.25

620

2232

Injuries to the head

632

2531

1.54

21.55

1.3

531.86

470.74

u/l

0.23

595

2396

Cough

223

1046

2.03

21.45

1.4

1.2

362.94

571.69

u/l

1.73

212

995

Asthma (diagnoses ohter than nonallergic)

509

2655

1.60

21.38

1.4

1.3

600.63

457.51

u/l

0.48

477

2516

Hypertensive Renal Disease

135

4.27

21.32

1.3

150.75

326.17

u/l

5.88

130

Nausea and vomiting

186

849

2.16

21.27

1.3

279.05

392.82

u/l

1.69

175

798

All influenza (not pneumonia)

248

3.25

20.93

1.4

1.3

306.12

344.41

u/l

0.29

237

Drug-induced neutropenia

201

3.55

20.77

1.3

493.47

347.89

u/l

0.81

195

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

591

2456

1.55

20.72

1.4

1.3

551.19

478.56

u/l

0.30

557

2326

Type 2 diabetes, definitions combined

534

1981

1.59

20.64

1.3

360.23

545.75

u/l

2.40

507

1874

394

2073

1.68

20.56

1.3

718.41

506.87

u/l

0.69

365

1970

Symptoms and signs involving the digestive system and abdomen

591

1904

1.56

20.49

1.4

1.3

434.29

545.65

u/l

0.64

555

1806

Lung transplant status

25.88

20.42

1.4

1.2

315.11

337.72

u/l

0.05

Lung transplantation

25.86

20.42

1.4

1.2

315.11

337.72

u/l

0.05

Glomerulonephritis

305

2.99

20.35

1.4

1.3

298.13

343.39

u/l

0.36

291

Other disorders of glucose regulation and pancreatic internal secretion

233

3.31

20.33

1.3

833.76

317.16

u/l

0.39

224

Benign neoplasm of colon, rectum, anus and anal canal

456

2464

1.61

20.25

1.4

1.3

493.03

471.57

u/l

0.05

429

2335

Other interstitial pulmonary diseases

157

702

2.27

20.11

1.4

1.3

479.39

377.26

u/l

0.68

145

664

Alcohol use disorder, Swedish definition

367

1989

1.70

20.08

1.3

726.43

490.44

u/l

0.74

340

1892

Type 2 diabetes, strict (exclude DM1)

535

2000

1.58

20.05

1.3

360.08

543.37

u/l

2.37

508

1890

Mental and behavioural disorders due to psychoactive substance use

374

2061

1.69

20.03

1.3

855.30

483.43

u/l

1.34

350

1954

Disorders of gallbladder, biliary tract and pancreas

599

2484

1.53

19.73

1.3

471.69

503.19

u/l

0.12

567

2353

ILD, hospital admissions

155

695

2.26

19.73

1.4

1.3

481.23

380.13

u/l

0.66

144

656

Osteopathies and chondropathies

345

1881

1.72

19.64

1.3

312.91

503.61

u/l

2.90

323

1781

Interstitial lung disease endpoints

157

710

2.24

19.58

1.4

1.3

479.39

376.97

u/l

0.69

145

672

Interstitial lung disease

157

710

2.24

19.58

1.4

1.3

479.39

376.97

u/l

0.69

145

672

Unspecified acute lower respiratory infection

120

483

2.51

19.44

1.3

577.51

358.22

u/l

0.96

111

458

Substance abuse

363

2036

1.68

19.25

1.3

868.77

487.32

u/l

1.33

339

1931

Clear cell adenocarcinoma of kidney

4.64

19.21

1.2

1.3

338.59

298.56

u/l

0.22

Pain, not elsewhere classified

156

708

2.22

19.16

1.3

686.41

404.69

u/l

0.91

147

673

Stroke, including SAH

466

2130

1.59

19.12

1.3

321.10

514.72

u/l

2.99

438

2020

Intestinal infectious diseases

662

2547

1.49

19.10

1.3

406.09

512.83

u/l

1.22

618

2415

Use of hypnotics and sedatives

613

2335

1.51

19.04

1.3

556.03

494.58

u/l

0.26

580

2210

Senile cataract

423

1587

1.64

18.86

1.4

1.3

303.03

500.03

u/l

4.05

398

1505

Persons encountering health services for other counselling and medical advice, not elsewhere classified

632

2293

1.50

18.85

1.4

1.3

572.06

484.58

u/l

0.34

602

2165

Lymphoid leukaemia

196

3.44

18.67

1.4

291.41

344.10

u/l

0.47

191

Factors influencing health status and contact with health services

173

390

2.24

18.48

1.3

357.80

549.59

u/l

1.28

164

369

Coronary artery bypass grafting

243

963

1.90

18.42

1.3

255.89

652.24

u/l

3.86

230

913

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

368

2236

1.65

18.34

1.4

1.3

417.25

495.41

u/l

0.25

349

2122

Dilated cardiomyopathy

124

524

2.40

18.18

1.3

568.49

363.86

u/l

0.23

118

499

Misadventures to patients during surgical and medical care

112

451

2.51

18.17

1.6

1.3

244.21

338.86

u/l

2.07

106

429

Reimbursement for rheumatic diseases

328

1938

1.69

17.99

1.3

484.02

511.44

u/l

0.16

313

1832

Hydronephrosis

356

2.70

17.86

1.2

1.3

558.78

322.70

u/l

0.79

341

Diseases of the skin and subcutaneous tissue

561

1848

1.53

17.79

1.3

372.70

516.24

u/l

1.91

530

1750

Convulsions, not elsewhere classified

137

600

2.27

17.79

1.4

1.3

891.06

535.07

u/l

0.42

127

573

Pain in limb

464

1982

1.57

17.72

1.4

1.3

375.50

495.70

u/l

1.45

432

1876

Coagulation defects, purpura and other haemorrhagic conditions

140

632

2.23

17.53

1.3

419.83

344.51

u/l

0.71

135

602

Other diseases of intestines

557

2097

1.51

17.50

1.4

1.3

454.31

534.86

u/l

0.51

530

1985

Other disorders of kidney and ureter

115

478

2.44

17.47

1.3

1.4

278.63

338.57

u/l

0.58

103

456

Intestinal stricture

237

1295

1.84

17.40

1.3

459.04

456.26

u/l

0.01

219

1229

Hypotension

167

811

2.08

17.39

1.3

784.54

384.09

u/l

0.62

158

759

ILD, hospital admissions 1, main diag only

137

618

2.25

17.27

1.4

1.3

492.30

330.56

u/l

1.78

126

584

Type 2 diabetes, definitions combined, including avohilmo

517

1976

1.53

17.02

1.3

363.30

550.38

u/l

2.37

490

1869

Alcoholic liver disease

361

2.64

16.89

1.3

1245.14

379.61

u/l

0.81

343

Idiopathic gout

104

420

2.52

16.89

1.4

1.3

346.99

364.17

u/l

0.07

401

Fracture of femur

236

1181

1.83

16.56

1.2

1.3

672.54

400.02

u/l

0.59

225

1108

Other soft tissue disorders, not elsewhere classified

519

2011

1.52

16.56

1.3

400.13

511.15

u/l

1.16

483

1903

Benign neoplasm: Colon

389

2350

1.59

16.49

1.4

1.3

363.67

494.14

u/l

1.20

363

2233

Stroke, excluding SAH

444

2099

1.55

16.30

1.3

320.24

513.25

u/l

2.87

415

1993

Unspecified haematuria

325

1632

1.66

16.13

1.4

1.3

471.13

505.28

u/l

0.09

302

1543

L04AX Other immunosuppressants

299

1788

1.68

15.98

1.4

1.3

539.02

500.71

u/l

0.22

288

1701

Ischaemic Stroke, excluding all haemorrhages

430

2070

1.55

15.95

1.3

297.86

517.12

u/l

3.57

400

1970

Other (not insulin) diabetes medications

541

2163

1.49

15.82

1.3

355.57

542.22

u/l

2.42

514

2047

Constipation

536

2511

1.48

15.80

1.3

533.38

480.85

u/l

0.23

500

2388

Paralytic ileus and intestinal obstruction

199

1062

1.89

15.77

1.3

499.00

524.46

u/l

0.06

185

1012

Open wound of head

349

2097

1.61

15.77

1.3

498.23

471.10

u/l

0.08

329

1984

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

172

881

1.97

15.46

1.3

610.86

346.23

u/l

3.23

164

835

Persons with potential health hazards related to communicable diseases

146

698

2.08

15.42

1.3

689.20

406.73

u/l

0.40

134

671

Acute bronchitis

268

1544

1.71

15.31

1.4

1.3

472.62

466.56

u/l

0.02

250

1461

Mental and behavioural disorders due to alcohol, excluding acute intoxication

285

1697

1.68

15.27

1.3

861.73

505.13

u/l

0.95

266

1618

Gastric ulcer

153

756

2.04

15.25

1.3

272.82

333.43

u/l

1.04

142

718

Second line medication for Crohn's disease

302

1834

1.65

15.24

1.4

1.3

536.31

502.27

u/l

0.20

291

1742

Chylothorax

45.78

15.21

1.7

1.2

169.89

131.80

u/l

—

Injuries to the hip and thigh

338

1911

1.61

15.09

1.3

587.99

466.18

u/l

0.32

323

1805

Symptoms and signs concerning food and fluid intake

300

2.69

15.03

1.2

1.3

788.34

340.85

u/l

0.71

286

Seropositive rheumatoid arthritis

174

900

1.94

15.03

1.3

606.70

420.12

u/l

1.44

166

846

Rheumatoid arthritis

220

1098

1.81

15.02

1.4

1.3

581.10

532.51

u/l

0.20

211

1049

Mental and behavioural disorders due to alcohol

319

1895

1.62

14.97

1.3

823.43

484.43

u/l

1.04

298

1799

Diabetic maculopathy, excluding more controls

336

2.59

14.95

1.3

201.42

368.80

u/l

3.81

322

Colorectal cancer

143

679

2.07

14.87

1.3

751.87

330.03

u/l

0.45

134

628

Bronchiectasis

255

2.82

14.59

1.6

1.3

464.38

341.21

u/l

0.62

242

Emphysema

272

2.76

14.56

1.2

1.3

430.43

333.37

u/l

0.65

255

Polyneuropathies and other disorders of the peripheral nervous system

173

912

1.91

14.35

1.3

302.93

491.60

u/l

1.34

164

863

Rheumatoid arthritis, including avohilmo

235

1359

1.74

14.33

1.3

565.96

391.59

u/l

1.76

224

1283

Retention of urine

285

1414

1.66

14.32

1.3

509.92

501.71

u/l

0.02

271

1341

Seropositive rheumatoid arthritis, wide

174

923

1.90

14.14

1.3

606.70

348.55

u/l

3.17

166

873

Other cataract

298

1380

1.64

14.07

1.3

565.93

469.98

u/l

0.18

289

1310

Other/unspecified seropositive rheumatoid arthritis

172

911

1.90

14.04

1.3

610.86

344.83

u/l

3.28

164

861

Sub-endpoint used in defining T1D endpoints

187

1002

1.85

13.93

1.3

226.62

416.46

u/l

4.08

176

947

Presence of other functional implants

385

1735

1.55

13.89

1.3

357.65

568.51

u/l

1.11

360

1649

Myocardial infarction, without ST-elevation

335

1944

1.58

13.86

1.3

399.54

491.40

u/l

0.32

315

1843

Benign neoplasms

522

1978

1.46

13.70

1.4

1.3

480.85

544.72

u/l

0.20

493

1879

Abnormalities of heart beat

182

971

1.84

13.59

1.3

252.76

552.97

u/l

3.11

175

919

Dermatitis

349

2250

1.55

13.58

1.4

1.3

405.34

512.75

u/l

0.94

333

2135

Biguanides

531

2247

1.44

13.51

1.3

386.03

531.14

u/l

1.46

500

2128

Medicines for HER+ breast cancer

173

881

1.87

13.38

1.3

416.03

369.71

u/l

0.16

165

831

Finngen Rheumatological endpoints

494

1924

1.46

13.33

1.3

379.12

552.41

u/l

2.21

466

1818

Malignant neoplasm of colon, including Hilmo

114

534

2.15

13.11

1.3

294.67

293.76

u/l

0.01

109

493

Alcohol use disorder, ICD-based

259

1580

1.65

12.98

1.3

859.49

495.93

u/l

0.88

242

1502

Fentanyl

367

2.39

12.87

1.4

1.3

323.39

426.57

u/l

0.43

343

Squamous cell neoplasms and carcinomas of the skin

258

2.67

12.60

1.3

230.03

264.10

u/l

0.36

242

Other special examinations and investigations of persons without complaint or reported diagnosis

365

1198

1.55

12.51

1.4

1.3

345.06

510.39

u/l

2.22

347

1135

Osteoporosis

179

931

1.81

12.42

1.4

1.3

283.54

335.81

u/l

0.67

169

876

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

221

2.79

12.38

1.6

1.3

192.30

343.20

u/l

4.12

213

Mycoses

168

921

1.84

12.37

1.3

388.61

368.42

u/l

0.14

156

874

Colorectal adenocarcinoma

118

574

2.06

12.27

1.2

1.3

290.59

293.27

u/l

0.02

110

533

Viral infections characterized by skin and mucous membrane lesions

226

1353

1.68

12.17

1.3

366.61

456.46

u/l

0.99

211

1282

Other and unspecified dermatitis

285

1809

1.58

12.15

1.4

1.3

367.11

552.33

u/l

2.20

271

1718

Diabetic retinopathy

251

945

1.67

12.13

1.3

1.4

413.68

381.94

u/l

0.06

238

892

L02BG Aromatase inhibitors

149

792

1.89

12.04

1.3

435.90

361.76

u/l

0.24

143

749

Cellulitis

141

740

1.92

11.92

1.4

1.3

800.94

368.19

u/l

0.70

135

711

220

1305

1.68

11.92

1.3

487.06

415.94

u/l

0.58

205

1231

Disorders of thyroid, IBD co-morbidities

255

2.38

11.80

1.3

1.2

378.23

632.69

u/l

0.91

246

Falls/tendency to fall

544

1937

1.41

11.75

1.3

576.95

442.93

u/l

0.44

509

1841

Candidiasis

145

775

1.88

11.59

1.4

1.3

370.19

383.58

u/l

0.08

137

737

Malignant melanoma

349

2.34

11.49

1.3

421.94

297.08

u/l

1.01

328

Hernia

503

2400

1.41

11.44

1.3

493.43

492.66

u/l

0.00

476

2272

Sequelae of external causes of morbidity and mortality

166

931

1.79

11.40

1.4

1.3

428.94

360.99

u/l

0.30

155

881

Other or unspecified ileus, impaction or obstruction

143

766

1.88

11.38

1.3

354.24

410.65

u/l

0.38

131

726

Decubitus ulcer and pressure area

255

2.59

11.36

1.3

1.4

461.43

337.69

u/l

0.34

246

Other and unspecified polyneuropathies, also in other diseases

150

819

1.85

11.28

1.4

1.3

288.48

382.41

u/l

1.30

142

775

Intracranial trauma

283

1268

1.57

11.24

1.3

465.56

535.46

u/l

0.28

268

1211

Examination and observation for other reasons

314

1176

1.55

11.22

1.3

810.20

514.02

u/l

0.58

300

1116

Injuries to the abdomen, lower back, lumbar spine and pelvis

243

1499

1.61

11.21

1.4

1.3

732.99

445.54

u/l

0.69

231

1415

General examination and investigation of persons without complaint and reported diagnosis

347

1194

1.52

11.16

1.4

1.3

376.84

511.71

u/l

1.47

330

1131

Fracture of lumbar spine and pelvis

161

901

1.80

11.09

1.4

1.3

697.07

385.33

u/l

0.51

150

846

Any operation in hilmo

+∞

11.02

1.4

0.0

247.50

—

u/l

—

Benzodiazepine use

537

2681

1.38

11.02

1.3

576.15

473.31

u/l

0.45

499

2544

Cutaneous abscess, furuncle and carbuncle

142

769

1.86

10.93

1.3

419.66

390.08

u/l

0.19

136

739

Duodenal ulcer

101

488

2.09

10.88

1.3

783.80

330.45

u/l

0.48

466

Seropositive rheumatoid arthritis, strict definition

436

2.15

10.80

1.4

704.59

342.75

u/l

3.08

413

Malignant neoplasm of colon

404

2.19

10.77

1.4

1.3

317.83

297.69

u/l

0.16

372

Fitting and adjustment of other devices

218

1205

1.64

10.71

1.4

1.3

323.45

499.90

u/l

1.59

211

1134

Supplementary factors related to causes of morbidity and mortality classified elsewhere

171

988

1.74

10.61

1.3

658.92

372.61

u/l

0.50

158

936

Persons encountering health services in other circumstances

203

1223

1.66

10.56

1.4

1.3

323.70

510.53

u/l

2.08

196

1158

Other external causes of accidental injury

427

1486

1.44

10.55

1.3

334.06

453.40

u/l

2.25

402

1408

Gastrointestinal diseases

244

752

1.63

10.47

1.4

1.3

372.16

484.90

u/l

1.42

235

718

Acute pancreatitis

135

731

1.86

10.45

1.3

854.93

432.99

u/l

0.54

122

690

Malignant melanoma, including Hilmo

443

2.11

10.38

1.4

1.3

395.54

292.90

u/l

0.92

413

Genitourinary diseases

296

960

1.55

10.34

1.3

359.21

661.00

u/l

3.44

281

923

Autoimmune diseases related-to ILD

430

2618

1.41

10.24

1.3

543.21

486.01

u/l

0.17

399

2485

Fracture of rib(s), sternum and thoracic spine

204

1249

1.64

10.23

1.3

643.59

483.95

u/l

0.50

195

1176

In situ neoplasms

237

1512

1.57

10.02

1.3

561.31

418.64

u/l

0.22

228

1423

Angina pectoris

333

1503

1.48

9.99

1.4

1.3

314.98

590.90

u/l

3.96

314

1425

Chronic apical periodontitis

585

2477

1.35

9.98

1.3

592.67

458.49

u/l

0.62

555

2340

Accidents

423

1486

1.43

9.97

1.3

330.18

453.40

u/l

2.39

398

1408

Diagnoses used for exclusion with ILD

179

1068

1.69

9.94

1.5

1.3

308.57

402.17

u/l

1.04

169

1007

Diarrhoea and gastroenteritis of presumed infectious origin

522

2528

1.36

9.88

1.3

435.47

509.43

u/l

0.63

489

2398

Obesity related asthma

180

1077

1.68

9.87

1.4

1.3

810.49

422.36

u/l

0.54

169

1026

Other symptoms and signs involving the digestive system and abdomen

428

2.09

9.71

1.4

1.3

375.81

372.58

u/l

0.02

403

Other infectious diseases

307

2.30

9.64

1.4

1.3

362.48

326.11

u/l

0.25

294

Other gastritis (incl. Duodenitis)

149

854

1.76

9.59

1.5

1.3

285.42

381.70

u/l

1.62

130

818

Type of accident

159

928

1.72

9.58

1.3

688.18

371.12

u/l

0.53

148

879

Congenital malformations, deformations and chromosomal abnormalities

234

1430

1.56

9.55

1.4

1.3

477.97

478.27

u/l

0.00

226

1353

Medical observation and evaluation for suspected diseases and conditions

344

1198

1.47

9.53

1.4

1.3

390.62

510.39

u/l

1.23

332

1135

Injuries to the thorax

283

1897

1.50

9.52

1.3

551.70

523.99

u/l

0.09

272

1785

Phlebitis and thrombophlebitis (not including DVT)

138

777

1.79

9.44

1.3

531.95

395.54

u/l

0.42

125

732

Substance use, excluding alcohol

453

2.04

9.43

1.2

1.3

1622.45

395.88

u/l

1.31

439

Symptoms and signs involving cognition, perception, emotional state and behaviour

508

2563

1.35

9.26

1.3

515.68

481.71

u/l

0.12

472

2439

Complications of cardiac and vascular prosthetic devices, implants and grafts

3.85

9.12

1.5

1.4

329.40

338.77

u/l

0.02

Diverticular disease of intestine

424

1956

1.39

8.92

1.3

349.77

518.40

u/l

2.27

402

1853

malignant neoplasm of male genital organs

177

646

1.68

8.91

1.4

540.34

467.88

u/l

0.16

165

606

Disorders of other endocrine glands

213

1341

1.57

8.90

1.3

308.39

376.26

u/l

1.22

196

1268

Other arthritis (FG)

170

1033

1.65

8.84

1.4

1.3

370.18

524.87

u/l

0.97

158

979

Persons encountering health services for examination and investigation

345

1198

1.45

8.78

1.4

1.3

362.74

510.39

u/l

1.83

329

1135

Persons encountering health services for specific procedures, not carried out

146

2.83

8.68

1.3

1.2

2049.56

340.28

u/l

0.78

138

Status post-ami

200

962

1.59

8.59

1.3

297.02

560.89

u/l

2.44

185

914

Periodontitis

509

2551

1.34

8.57

1.3

527.19

490.22

u/l

0.16

481

2416

Lung diseases due to external agents

117

649

1.82

8.50

1.4

1.3

338.88

380.44

u/l

0.22

109

613

Chronic periodontitis, including avohilmo

506

2545

1.33

8.45

1.3

527.11

490.92

u/l

0.16

478

2411

Vascular disorders of the intestines

274

2.29

8.45

1.5

1.3

280.10

286.33

u/l

0.04

262

Thyrotoxicosis with toxic multinodular goitre

177

2.63

8.44

1.5

1.3

387.09

303.74

u/l

0.26

170

Congenital malformations, deformations and chromosomal abnormalities

256

1588

1.49

8.39

1.4

1.3

468.21

537.69

u/l

0.22

247

1504

Zoster [herpes zoster]

122

688

1.78

8.38

1.3

291.79

334.17

u/l

0.57

114

651

Abdominal and pelvic pain

508

1904

1.34

8.36

1.4

1.3

484.03

545.65

u/l

0.25

479

1806

Sequelae with surgical and medical care as external cause

129

740

1.75

8.35

1.4

1.3

399.59

349.35

u/l

0.18

123

701

Other specified/unspecified arthritis

152

912

1.67

8.34

1.4

1.3

380.02

511.24

u/l

0.73

140

874

Other antidepressants

564

2192

1.32

8.33

1.4

1.3

547.70

455.71

u/l

0.41

528

2081

Other nutritional deficiencies

288

1874

1.45

8.30

1.3

587.15

496.85

u/l

0.22

274

1777

Injury, poisoning and certain other consequences of external causes

267

892

1.50

8.25

1.4

1.3

329.27

430.72

u/l

1.38

255

841

Open wound of lower leg

436

1.98

8.21

1.3

380.07

350.71

u/l

0.14

420

Unstable angina pectoris

250

1323

1.50

8.20

1.4

1.3

324.92

599.60

u/l

3.10

229

1259

Covid-19 suspected case

450

1.96

8.18

1.5

1.3

377.89

368.65

u/l

0.06

428

Diabetic retinopathy, strict definition

119

591

1.79

8.11

1.3

203.79

429.69

u/l

3.22

112

561

Thyrotoxicosis

120

682

1.77

8.02

1.3

298.36

373.82

u/l

0.58

113

644

Aortic aneurysm

186

1163

1.58

8.01

1.3

354.39

541.80

u/l

1.46

175

1111

Acute pancreatitis (for exclusion)

135

795

1.71

7.98

1.3

854.93

412.47

u/l

0.58

122

758

Malignant neoplasm of prostate

173

636

1.63

7.94

1.4

542.69

466.59

u/l

0.16

161

596

Exposure to unspecified factor

496

2701

1.32

7.94

1.3

520.43

485.02

u/l

0.12

476

2548

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

510

1.88

7.87

1.3

535.99

379.78

u/l

1.33

496

Benign neoplasm: Ascending colon

102

557

1.85

7.83

1.6

1.3

219.15

344.35

u/l

3.74

532

Systemic connective tissue disorders

194

1256

1.55

7.81

1.3

480.65

400.96

u/l

0.32

183

1182

Abnormal results of function studies

196

2.47

7.81

1.5

1.3

414.84

344.13

u/l

0.37

191

Delirium, not induced by alcohol and other psychoactive substances

102

557

1.84

7.79

1.2

1.3

656.39

393.57

u/l

0.44

524

Corns and callosities

191

2.49

7.74

1.3

1.4

313.13

329.17

u/l

0.10

182

Cholelithiasis, broad definition with cholecystitis

469

2378

1.33

7.69

1.3

488.91

500.90

u/l

0.03

440

2253

Asthma, hospital admissions , main diagnosis only

401

2621

1.35

7.65

1.4

1.3

428.74

495.76

u/l

0.46

370

2487

Neurological diseases, wide definition

105

279

1.89

7.65

1.3

1.2

347.11

636.32

u/l

1.47

269

Other noninfective gastroenteritis and colitis

130

767

1.70

7.62

1.3

462.26

351.58

u/l

0.33

117

727

Other infectious diseases

262

2.24

7.54

1.4

1.3

329.49

336.55

u/l

0.04

252

Familial hypercholesterolemia

109

615

1.78

7.53

1.4

1.3

293.62

523.98

u/l

1.13

103

578

Noninfective enteritis and colitis

225

1519

1.48

7.40

1.3

399.14

492.58

u/l

0.44

209

1442

Asthma, including avohilmo

594

2599

1.29

7.39

1.4

1.3

634.31

460.21

u/l

0.71

559

2461

Arterial embolism and thrombosis

215

2.35

7.30

1.3

222.14

369.14

u/l

2.15

205

Other symptoms and signs involving the urinary system

401

1.96

7.23

1.5

1.3

304.52

367.61

u/l

0.56

383

Use of anticholinesterases

126

1629

0.61

7.18

1.3

363.33

444.74

u/l

0.57

111

1532

N06DA Anticholinesterases

126

1629

0.61

7.18

1.3

363.33

444.74

u/l

0.57

111

1532

Respiratory tuberculosis

224

2.31

7.12

1.3

473.47

334.64

u/l

0.89

213

Respiratory tuberculosis, confirmed and not-confirmed

224

2.31

7.12

1.3

473.47

334.64

u/l

0.89

213

Concussion

228

1264

1.48

7.12

1.4

1.3

493.39

536.18

u/l

0.13

216

1208

Tuberculosis, IBD comorbidity

295

2.12

7.12

1.4

1.3

434.47

293.12

u/l

1.22

283

Malignant neoplasm of rectum

245

2.22

6.96

1.3

1509.86

271.74

u/l

0.49

230

Thyrotoxicosis, other and/or unspecified

513

1.82

6.94

1.4

232.78

393.73

u/l

2.77

484

Poisoning by drugs, medicaments and biological substances

492

1.84

6.91

1.3

584.86

389.37

u/l

1.53

476

Degeneration of macula and posterior pole

330

1918

1.37

6.90

1.3

340.89

451.61

u/l

0.84

312

1807

Tuberculosis

266

2.17

6.89

1.3

442.32

318.02

u/l

0.89

254

Malignant melanoma of skin, including Hilmo

353

1.99

6.86

1.4

1.3

414.47

294.55

u/l

0.90

333

External causes of morbidity and mortality

311

1112

1.40

6.84

1.4

1.3

340.77

467.22

u/l

1.82

298

1051

Other and unspecified local infections of skin and subcutaneous tissue

280

2.12

6.82

1.4

1.3

361.47

341.40

u/l

0.10

269

Intracranial injury

308

2117

1.38

6.78

1.3

412.02

475.96

u/l

0.30

291

2006

Unspecified fall

273

1921

1.40

6.72

1.3

839.41

468.97

u/l

0.86

260

1824

Cholecystitis

564

1.77

6.67

1.3

964.43

400.53

u/l

0.55

530

Other local infections of skin and subcutaneous tissue

303

2.06

6.64

1.4

1.3

358.72

337.54

u/l

0.11

292

Pain (limb, back, neck, head abdominally)

394

1472

1.34

6.64

1.4

1.3

431.66

562.56

u/l

0.55

372

1398

Sequelae of cerebrovascular disease

257

1567

1.42

6.62

1.4

1.3

335.24

493.60

u/l

1.54

242

1489

Diabetic maculopathy

436

1.85

6.60

1.3

202.55

353.18

u/l

2.27

415

Malignant neoplasm of rectum, including Hilmo

324

2.02

6.59

1.3

1280.67

283.53

u/l

0.48

304

Disorder of lipoprotein metabolism, unspecified

525

1.78

6.48

1.2

1.3

434.29

345.49

u/l

0.52

495

Viral infections characterized by skin and mucous membrane lesions

409

2666

1.31

6.47

1.3

371.33

507.57

u/l

2.27

389

2519

Malignant neoplasm of prostate, including Hilmo

170

652

1.56

6.46

1.4

461.94

469.50

u/l

0.02

160

611

Small cell lung cancer, helper endpoint

108

2.83

6.36

1.2

1.3

456.62

304.51

u/l

0.55

103

Tuberculosis, wide

311

2.01

6.23

1.4

1.3

434.47

429.14

u/l

0.01

299

Adenocarcinoma and papilloma adenocarcinoma of rectum

244

2.15

6.21

1.3

281.90

271.75

u/l

0.06

228

Pneumonitis due to solids and liquids

353

1.94

6.20

1.5

1.3

302.78

325.00

u/l

0.18

333

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

151

979

1.55

6.15

1.3

327.60

385.62

u/l

0.55

144

934

Retinal vascular occlusion

513

1.77

6.11

1.3

297.38

334.06

u/l

0.26

482

Weight loss

334

1.96

6.10

1.2

1.4

775.85

343.07

u/l

0.51

319

Retinal vascular disorders

529

1.75

6.06

1.3

295.22

407.98

u/l

0.63

496

Any mental disorder

558

2213

1.26

6.06

1.3

710.33

435.23

u/l

1.49

523

2109

Other condition

378

1.89

5.99

1.3

416.70

359.73

u/l

0.38

365

Zoster [herpes zoster]

274

1969

1.37

5.97

1.4

1.3

313.56

473.75

u/l

2.66

262

1867

Thoracic aortic aneurysm

585

1.70

5.92

1.4

1.3

359.57

535.84

u/l

0.75

557

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

256

2.08

5.90

1.2

1.3

279.38

272.29

u/l

0.04

240

Chronic periodontitis, complicated

290

2122

1.36

5.90

1.3

567.11

497.06

u/l

0.24

273

2023

Other functional intestinal disorders

246

1639

1.40

5.89

1.3

592.97

510.08

u/l

0.21

226

1555

Sulfonylureas

259

1490

1.39

5.87

1.4

1.3

248.36

474.13

u/l

3.70

241

1416

Acute upper respiratory infections of multiple and unspecified sites

339

1891

1.33

5.82

1.3

441.11

544.21

u/l

0.76

322

1788

Malignant neoplasm of cervix uteri, including Hilmo

6.92

5.75

1.1

181.23

252.05

u/l

0.42

Obesity

257

1804

1.38

5.72

1.4

1.3

444.84

525.85

u/l

0.60

242

1718

Unspecified jaundice

163

2.36

5.67

1.1

1.3

679.95

317.86

u/l

0.36

155

Gastro-oesophageal reflux disease

334

2182

1.32

5.64

1.4

1.3

661.45

480.89

u/l

0.45

313

2084

Malignant melanoma of skin

261

2.04

5.62

1.3

477.47

288.46

u/l

1.24

245

Alcohol dependence

152

1010

1.51

5.58

1.3

1095.92

517.34

u/l

0.87

142

963

Obesity and other hyperalimentation

257

1813

1.37

5.51

1.4

1.3

444.84

524.44

u/l

0.59

242

1727

Benign neoplasm: Colon, unspecified

166

1127

1.48

5.51

1.4

1.3

357.79

478.62

u/l

0.82

151

1068

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

277

1.99

5.48

1.2

1.3

718.31

403.30

u/l

1.75

267

Other neurological diseases

412

2531

1.28

5.44

1.4

1.3

322.59

499.85

u/l

2.71

386

2396

Obesity, other/unspecified

130

840

1.55

5.43

1.4

1.3

500.14

392.08

u/l

0.83

122

803

Obesity due to excess calories

185

1288

1.44

5.37

1.4

1.3

447.77

562.07

u/l

0.67

174

1228

Diseases of the musculoskeletal system and connective tissue

240

860

1.40

5.36

1.4

1.3

369.92

608.32

u/l

1.73

229

822

Other viral diseases

106

658

1.61

5.20

1.3

434.56

385.62

u/l

0.27

635

Schizophrenia or delusion, excluding more controls

118

746

1.57

5.20

1.3

543.01

353.72

u/l

2.41

111

716

DVT of lower extremities

117

747

1.57

5.19

1.3

602.08

426.36

u/l

0.44

107

698

Poisoning by medicine

426

1.77

5.19

1.2

1.3

604.11

395.40

u/l

1.38

411

Fracture of foot, except ankle

100

615

1.63

5.17

1.3

474.11

387.19

u/l

0.51

591

Mycoses

394

2688

1.28

5.14

1.3

534.91

494.09

u/l

0.09

371

2544

Soft tissue disorders

493

2026

1.25

5.13

1.4

1.3

334.45

509.36

u/l

2.98

463

1917

Dental operations

382

1518

1.30

5.13

1.4

1.3

296.31

471.03

u/l

2.45

364

1429

Noninfectious colitis NAS

377

1.81

5.11

1.3

1.4

222.25

332.75

u/l

2.00

360

Actinic keratosis

267

1846

1.34

5.09

1.3

380.04

428.61

u/l

0.24

252

1742

Other reaction to severe stress, and adjustment disorders

112

712

1.58

5.05

1.3

367.42

410.75

u/l

0.40

104

678

Suicide or other Intentional self-harm

566

1.65

5.02

1.3

549.06

383.93

u/l

1.39

541

Symptoms and signs involving the skin and subcutaneous tissue

338

2559

1.29

5.01

1.3

457.54

491.41

u/l

0.18

316

2425

Sleep apnoea

469

2428

1.25

5.01

1.4

1.3

528.48

505.27

u/l

0.06

440

2308

Unspecified protein-energy malnutrition

6.29

4.99

1.4

1.2

173.93

219.36

u/l

0.23

281

1944

1.33

4.99

1.3

372.96

428.74

u/l

0.30

265

1834

Statin medication

281

1179

1.34

4.96

1.3

320.76

600.78

u/l

3.01

269

1113

Cholelithiasis

430

2355

1.26

4.92

1.3

388.07

500.38

u/l

0.70

402

2231

Fracture of lower leg, including ankle

261

1936

1.34

4.89

1.3

745.89

484.49

u/l

0.48

244

1844

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

595

1.62

4.83

1.3

535.99

387.14

u/l

1.25

569

Skin changes due to chronic exposure to nonionizing radiation

270

1878

1.33

4.83

1.3

379.68

427.83

u/l

0.24

255

1772

Chronic diseases of tonsils and adenoids

179

1591

0.71

4.82

1.3

503.36

530.07

u/l

0.10

169

1521

Other skin changes

110

706

1.57

4.81

1.4

1.3

547.31

350.97

u/l

0.57

103

667

Abnormal weight loss

313

1.87

4.79

1.3

1.4

355.41

352.39

u/l

0.02

300

Exclusions for E4_PCOS_CONSORTIUM

237

1092

1.36

4.70

1.3

509.78

407.44

u/l

0.40

222

1037

Superficial injury of head

119

782

1.53

4.67

1.3

776.92

361.93

u/l

0.52

112

739

Disorders of parathyroid gland

117

757

1.53

4.67

1.4

1.3

241.75

349.77

u/l

1.88

108

710

Right hemicolectomy

226

2.01

4.61

1.2

1.3

247.00

326.43

u/l

0.98

219

Benign neoplasm: Sigmoid colon

118

778

1.52

4.59

1.5

1.3

288.62

353.86

u/l

1.00

112

736

Insomnia

219

2150

0.74

4.58

1.3

497.69

508.23

u/l

0.03

205

2035

Diaphragmatic hernia

201

1469

1.37

4.50

1.4

1.3

525.78

450.75

u/l

0.25

192

1393

Restrictive cardiomyopathy

6.68

4.39

1.3

135.90

180.04

u/l

—

Infections with a predominantly sexual mode of transmission

486

1.65

4.37

1.2

1.3

403.89

401.70

u/l

0.01

462

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

231

1.96

4.34

1.5

1.3

319.74

345.97

u/l

0.16

225

218

1411

1.35

4.33

1.3

378.84

435.81

u/l

0.22

203

1329

Diseases of the eye and adnexa

324

1258

1.29

4.33

1.4

1.3

354.43

515.35

u/l

3.01

308

1194

Exclusions for E4_PCOS_BROAD

435

1.68

4.32

1.2

1.4

376.83

358.99

u/l

0.12

418

Chronic gastritis

162

1154

1.41

4.26

1.4

1.3

604.31

411.82

u/l

0.29

153

1101

Cardiomyopathies, Secondary/extrinsic

7.13

4.20

1.3

1.7

213.67

369.54

u/l

—

Leisure time condition

564

1.58

4.16

1.4

896.04

333.19

u/l

0.54

539

Other viral diseases

122

821

1.48

4.16

1.3

411.48

401.51

u/l

0.05

114

785

Any prescribed medicine buy

+∞

4.15

1.6

0.0

158.20

—

u/l

—

Dermatitis and eczema

524

2687

1.21

4.12

1.4

1.3

385.76

509.72

u/l

1.63

498

2538

Sensorineural hearing loss

428

2359

1.23

4.12

1.3

359.44

507.87

u/l

1.81

404

2231

Benign neoplasm of other and ill-defined parts of digestive system

645

1.54

4.11

1.3

269.06

352.38

u/l

0.89

612

Unspecific neurodegenerative disorder

188

1737

0.74

4.08

1.2

1.3

423.24

428.82

u/l

0.02

174

1647

Dentofacial anomalies [including malocclusion]

126

1458

0.69

4.07

1.4

1.3

365.24

451.60

u/l

0.76

119

1394

Retinal detachments and breaks

209

1564

1.34

4.07

1.3

514.67

518.90

u/l

0.01

201

1485

Osteoporosis with pathological fracture (FG)

230

1.93

4.06

1.3

211.97

369.25

u/l

0.94

212

Fracture of shoulder and upper arm

180

1315

1.37

4.05

1.3

615.15

400.13

u/l

0.38

172

1241

Progressive systemic sclerosis

10.37

4.05

1.4

1.1

161.00

147.10

u/l

—

Dizziness and giddiness

379

2419

1.24

4.03

1.3

363.69

473.72

u/l

1.35

354

2302

Idiopathic pulmonary fibrosis

370

1.72

4.00

1.5

1.3

476.12

314.62

u/l

1.53

353

Hyperparathyroidism

100

650

1.53

3.99

1.4

1.3

198.58

323.06

u/l

4.05

609

Conductive and sensorineural hearing loss

436

2403

1.23

3.97

1.3

358.32

513.10

u/l

1.99

412

2273

Neurological diseases

390

1573

1.25

3.96

1.4

1.3

362.99

516.95

u/l

2.31

366

1499

Schizophrenia, schizotypal and delusional disorders

119

813

1.47

3.94

1.3

541.07

367.67

u/l

2.12

112

774

Injuries to the elbow and forearm

302

2093

1.27

3.92

1.2

1.3

673.30

484.22

u/l

0.46

281

1987

Protein-energy malnutrition of moderate and mild degree

4.91

3.90

1.8

1.3

276.55

260.32

u/l

0.04

Selective deficiency of immunoglobulin G [IgG] subclasses

7.46

3.89

1.6

1.4

477.00

285.43

u/l

—

Explicit fungal Sepsis

5.44

3.87

1.8

1.7

343.40

242.72

u/l

—

Osteonecrosis

172

2.05

3.85

1.3

1.4

503.34

330.30

u/l

0.81

166

Schizophrenia or delusion

118

809

1.46

3.85

1.3

543.01

370.77

u/l

2.07

111

771

Arthropathies

405

1662

1.24

3.82

1.4

1.3

446.65

542.92

u/l

0.39

379

1581

Chronic myeloid leukaemia

9.08

3.81

1.6

1.4

474.14

481.13

u/l

—

Caries of dentine, including avohilmo

435

1815

1.23

3.81

1.4

1.3

338.97

427.97

u/l

1.46

409

1712

Sleep disorders

240

2241

0.77

3.79

1.3

484.21

513.51

u/l

0.09

225

2123

Diseases of pulp and periapical tissues, including avohilmo

521

2245

1.20

3.79

1.3

418.16

465.93

u/l

0.32

498

2117

Injuries to the ankle and foot

260

1800

1.29

3.74

1.3

541.11

536.04

u/l

0.02

239

1715

Other systemic involvement of connective tissue (FG)

128

886

1.43

3.72

1.3

539.59

424.23

u/l

0.31

120

829

Transient ischemic attack

316

2041

1.26

3.70

1.4

1.3

296.65

501.10

u/l

2.60

299

1943

Dental pulpitis, including avohilmo

227

1913

0.77

3.69

1.3

455.99

544.03

u/l

0.72

216

1815

Ulcer of oesophagus

260

1.82

3.68

1.3

280.33

342.49

u/l

0.50

249

Other and unspecified drugs and medicaments

224

1.89

3.68

1.4

1.3

276.19

341.15

u/l

0.67

217

Abdominal aortic aneurysm (AAA)

554

1.55

3.67

1.2

1.3

398.46

471.55

u/l

0.25

527

Hypothyroidism, strict autoimmune

328

1727

1.25

3.62

1.3

476.15

523.73

u/l

0.12

311

1635

Gonarthrosis, primary, with knee surgery

221

2276

0.77

3.58

1.4

1.3

355.46

505.50

u/l

1.88

212

2148

Disease of hard tissues of teeth, NOS

188

1307

0.75

3.56

1.5

1.3

368.34

439.67

u/l

0.67

181

1234

154

1058

1.37

3.53

1.3

397.10

406.30

u/l

0.02

141

991

Sequelae of injuries, of poisoning and of other consequences of external causes

102

694

1.47

3.50

1.3

454.00

373.93

u/l

0.37

666

Alzheimer disease, including avohilmo

164

1552

0.74

3.50

1.2

1.3

471.20

440.85

u/l

0.10

148

1463

Contact with and exposure to communicable diseases

454

1.58

3.43

1.4

1.3

300.97

428.68

u/l

1.97

437

Malignant neoplasm of cervix uteri

7.07

3.37

1.0

1.1

211.43

344.30

u/l

—

Umbilical hernia

135

975

1.39

3.37

1.2

1.3

432.63

571.76

u/l

0.65

125

929

Dermatophytosis

484

1.56

3.33

1.4

1.3

390.03

351.97

u/l

0.20

466

Benign neoplasm: Adrenal gland

247

1.79

3.32

1.3

1.4

289.23

340.54

u/l

0.43

238

Other diseases of anus and rectum

161

1199

1.34

3.27

1.4

1.3

563.11

510.16

u/l

0.10

153

1140

Use of antiglaucoma preparations and miotics

324

1.68

3.24

1.3

1.4

759.53

317.10

u/l

0.45

307

Coeliac disease

301

1.70

3.23

1.3

1.4

245.24

347.13

u/l

1.38

291

Dorsalgia

462

2072

1.20

3.23

1.3

410.26

497.78

u/l

0.71

436

1966

Perforation of oesophagus

5.52

3.22

1.0

1.3

572.25

224.15

u/l

—

Exposure to other specified factors

312

2326

1.23

3.22

1.3

718.53

490.27

u/l

0.64

301

2203

Diseases of oral cavity, salivary glands and jaws

350

1467

1.23

3.21

1.4

1.3

310.35

426.66

u/l

2.02

332

1381

Dental caries, including avohilmo

414

1755

1.21

3.21

1.4

1.3

322.93

434.50

u/l

2.03

390

1651

Psychiatric diseases

484

2037

1.19

3.21

1.3

549.97

448.64

u/l

0.53

453

1940

Endometroid carcinoma of ovary, including Hilmo

6.48

3.20

1.4

1.0

238.29

320.00

u/l

—

Inguinal hernia

322

1751

1.23

3.15

1.4

1.3

550.66

521.04

u/l

0.08

309

1656

Fluid overload

7.84

3.09

1.5

1.3

93.17

160.50

u/l

—

Erectile dysfunction, exclusion

7.78

3.08

2.0

1.5

187.33

275.38

u/l

—

Other systemic involvement of connective tissue

131

958

1.37

3.07

1.3

533.80

394.27

u/l

0.42

123

904

Injuries to the knee and lower leg

550

2609

1.17

3.06

1.3

564.34

477.03

u/l

0.29

511

2480

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

5.95

3.04

1.1

1.2

363.43

179.47

u/l

—

Disorders of skin appendages

175

1338

1.31

3.01

1.4

1.3

389.36

447.44

u/l

0.42

169

1269

Dementia in Alzheimer disease

890

0.66

3.00

1.3

297.56

350.80

u/l

0.40

846

Injury of nerves and spinal cord at thorax level

10.22

2.99

1.0

1.2

856.00

214.80

u/l

—

Sleep apnoea, including avohilmo

468

2454

1.18

2.98

1.4

1.3

533.33

502.40

u/l

0.08

441

2332

Behavioural syndromes associated with physiological disturbances and physical factors

266

2329

0.81

2.94

1.3

472.43

531.26

u/l

0.21

250

2209

Phobic anxiety disorders

148

1.96

2.92

1.3

1348.77

352.97

u/l

0.61

141

Benign neoplasm of other and unspecified endocrine glands

405

1.56

2.89

1.3

1.4

261.39

332.23

u/l

1.07

391

Functional dyspepsia

110

791

1.39

2.87

1.3

369.66

405.58

u/l

0.25

101

761

Disorders of continuity of bone

214

1.78

2.87

1.4

350.75

371.87

u/l

0.07

207

Other disorders of ear

449

2493

1.18

2.86

1.3

355.77

511.60

u/l

2.64

426

2358

Spondylopathies

403

2021

1.19

2.85

1.3

572.24

482.02

u/l

0.29

377

1919

Colectomy operation

687

1.42

2.79

1.2

1.3

266.31

341.22

u/l

1.12

654

Spondyloarthritis

579

1.45

2.78

1.2

1.3

1042.29

342.14

u/l

0.60

550

Other diseases of urinary system

487

2338

1.17

2.78

1.4

1.3

387.45

513.91

u/l

1.39

460

2215

Palmar fascial fibromatosis [Dupuytren]

106

763

1.40

2.78

1.4

1.3

294.48

560.62

u/l

1.74

101

721

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

8.65

2.77

1.2

297.20

230.00

u/l

—

Acute sinusitis

182

1313

1.28

2.74

1.4

1.3

588.51

488.64

u/l

0.27

167

1242

Henoch-Schönlein purpura nephritis (HSPN)

6.21

2.72

1.3

118.17

191.46

u/l

—

Viral and other specified intestinal infections

529

1.46

2.72

1.3

311.20

385.30

u/l

0.98

502

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

3.02

2.69

1.2

1.4

827.50

323.53

u/l

0.76

Dementia, including avohilmo

214

1838

0.80

2.68

1.2

1.3

390.68

426.04

u/l

0.17

202

1743

Disorders of the thyroid gland

443

2462

1.17

2.64

1.3

441.87

498.30

u/l

0.20

422

2325

Hernia of abdominal wall

227

1830

1.24

2.63

1.3

383.42

543.42

u/l

1.52

212

1741

Fibroblastic disorders

135

1020

1.33

2.62

1.4

1.3

325.14

560.74

u/l

1.75

128

966

Use of other anti-dementia drugs

124

1366

0.75

2.61

1.3

353.23

404.65

u/l

0.36

111

1284

Use of memantine

124

1366

0.75

2.61

1.3

353.23

404.65

u/l

0.36

111

1284

Drug-induced polyneuropathy

3.67

2.59

1.1

1.3

610.56

244.39

u/l

—

Nosocomial condition (hospital)

4.11

2.59

1.8

1.4

394.41

244.36

u/l

—

Other diseases of liver

514

1.46

2.59

1.4

1.3

375.42

366.09

u/l

0.03

495

Cardiomyopathy due to drugs and other external agents

7.54

2.59

1.4

1.3

240.20

283.90

u/l

—

Inflammatory diseases of the central nervous system

207

1.75

2.57

1.2

1.3

242.77

336.78

u/l

0.82

200

Nerve, nerve root and plexus disorders

506

2678

1.16

2.56

1.4

1.3

355.80

511.52

u/l

2.80

471

2540

Fracture of forearm

225

1663

1.24

2.56

1.2

1.3

583.56

415.02

u/l

0.53

208

1582

Previous suicide attempt

5.52

2.55

1.8

1.3

285.00

231.36

u/l

—

Diseases of pulp and periapical tissues and dental caries

367

1581

1.19

2.53

1.4

1.3

332.08

416.55

u/l

1.23

350

1486

Other disorders of veins

174

1361

1.27

2.50

1.3

657.35

467.31

u/l

0.55

167

1285

Epilepsy

149

1146

1.30

2.50

1.3

422.34

512.39

u/l

0.54

143

1093

Cachexia

3.92

2.49

1.9

1.2

100.38

331.15

u/l

—

Infections with a predominantly sexual mode of transmission

590

1.41

2.49

1.2

1.3

388.26

414.23

u/l

0.18

563

Other symptoms and signs involving cognitive functions and awareness

261

1955

1.22

2.48

1.3

448.05

475.84

u/l

0.10

237

1861

Procreative management

520

1.41

2.48

1.3

344.69

414.90

u/l

0.71

498

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

3.19

2.45

1.1

1.5

367.47

232.32

u/l

—

Diseases of external ear

157

1224

1.29

2.44

1.4

1.3

793.90

482.16

u/l

0.46

144

1156

Benign neoplasm: Connective and other soft tissue of thorax

5.14

2.42

1.0

1.3

338.67

230.97

u/l

—

Dementia

203

1732

0.80

2.42

1.2

1.4

416.37

418.81

u/l

0.01

190

1645

Gingivitis and periodontal diseases

505

2258

1.15

2.42

1.3

464.47

453.42

u/l

0.05

484

2129

Liposarcoma

5.09

2.41

1.0

1.6

237.83

392.75

u/l

—

Benign neoplasm of other and unspecified intrathoracic organs

3.39

2.40

1.7

1.2

212.89

279.68

u/l

—

Intestinal helminthiases, other/unspecified

6.50

2.40

1.8

1.1

136.00

394.20

u/l

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

229

1815

1.23

2.39

1.4

1.3

455.43

555.17

u/l

0.56

216

1736

Serous carcinoma of ovary

6.35

2.38

1.0

1.3

493.00

129.13

u/l

—

Malignant neoplasm of vulva

6.32

2.38

1.0

846.80

98.11

u/l

—

Benign neoplasm: Stomach

321

1.56

2.37

1.3

1.4

212.73

319.88

u/l

1.75

313

Use of donepezil

1078

0.72

2.35

1.3

358.75

391.99

u/l

0.19

1014

Low back pain

334

2027

1.18

2.32

1.3

499.89

498.57

u/l

0.01

310

1924

Complications of internal orthopaedic prosthetic devices, implants and grafts

122

927

1.32

2.32

1.4

1.3

268.99

442.17

u/l

2.09

116

876

Caries of enamel

239

2089

0.82

2.29

1.3

546.74

523.93

u/l

0.08

230

1983

Marginal zone B-cell lymphoma

4.68

2.28

1.3

1.1

166.53

342.20

u/l

—

Symptoms and signs involving the nervous and musculoskeletal systems

270

2253

1.20

2.27

1.3

533.99

492.64

u/l

0.09

257

2136

Burns and corrosions of multiple body regions

3.95

2.26

1.0

1.2

418.57

340.33

u/l

—

Psoriasis

122

931

1.31

2.25

1.3

580.87

376.87

u/l

0.46

113

884

Disorders of eyelid, lacrimal system and orbit

405

2657

1.16

2.18

1.3

329.75

502.69

u/l

3.20

383

2512

Other anxiety disorders

123

817

1.31

2.17

1.3

521.29

398.83

u/l

0.94

115

779

Missing teeth due to accident, extraction or parodontitis

298

2375

1.18

2.16

1.3

518.09

489.28

u/l

0.13

281

2254

Malignant neoplasm of bladder

242

1.62

2.15

1.3

338.89

277.39

u/l

0.37

227

Fall on and from stairs and steps

115

878

1.31

2.14

1.4

1.3

1329.55

357.64

u/l

0.78

107

835

Psoriasis vulgaris

604

1.38

2.12

1.4

1.3

675.90

377.49

u/l

0.46

579

Other disorders of bone

473

1.42

2.05

1.4

1.3

354.96

397.19

u/l

0.32

454

Periapical abscess

180

1461

1.23

2.05

1.3

467.26

561.53

u/l

0.44

167

1391

Benign neoplasm: Rectum, anus and anal canal

112

859

1.31

2.04

1.5

1.3

886.68

347.93

u/l

0.45

105

808

Melanoma in situ

162

1.74

2.02

1.3

542.46

353.22

u/l

0.62

156

Macular pucker

653

1.35

2.01

1.3

289.80

504.32

u/l

1.21

616

Anxiety (asthma-related co-morbidities)

174

1087

1.24

2.00

1.3

704.07

404.39

u/l

1.15

164

1039

Shoulder lesions

370

1934

1.16

2.00

1.3

371.40

497.30

u/l

1.60

350

1832

Hydrocele

594

1.37

2.00

1.3

991.49

590.98

u/l

0.33

572

Alzheimer’s disease, strict definition

115

1220

0.77

2.00

1.3

458.30

387.65

u/l

0.21

101

1150

Other and unspecified injuries of head

193

1.66

1.99

1.4

1.3

1589.69

311.95

u/l

0.44

187

Alcohol abuse, main dg, excluding more controls

418

1.44

1.98

1.2

1.3

633.22

357.64

u/l

1.06

405

Primary gonarthrosis, bilateral

205

2116

0.83

1.95

1.4

1.3

359.28

510.71

u/l

1.83

196

2000

Coxarthrosis [arthrosis of hip](FG)

288

1723

1.18

1.94

1.4

1.3

327.84

542.46

u/l

2.06

273

1629

Non-selective monoamine reuptake inhibitors

176

1384

1.23

1.92

1.3

777.84

476.21

u/l

0.53

165

1316

Alzheimer disease

155

1403

0.81

1.90

1.3

459.13

399.69

u/l

0.22

137

1324

Other disorders of urethra and urinary system

329

2045

1.16

1.89

1.3

407.01

497.97

u/l

0.63

305

1937

Ventricular septal defect, a heart condition

3.19

1.87

1.7

1.2

147.43

366.65

u/l

—

Papulosquamous disorders

167

1362

1.23

1.85

1.4

1.3

516.28

468.61

u/l

0.11

156

1296

Malignant neoplasm of vulva, including Hilmo

3.56

1.84

1.0

1.2

964.00

170.60

u/l

—

Maze procedure for atrial fibrillation

4.26

1.83

2.6

1.3

155.32

129.33

u/l

—

Visual disturbances and blindness

233

1963

1.19

1.83

1.3

286.33

510.08

u/l

4.01

220

1858

Appendectomy

230

1850

1.19

1.83

1.4

1.3

392.17

546.86

u/l

1.62

220

1759

Injuries to the shoulder and upper arm

389

2745

1.14

1.81

1.3

547.67

484.29

u/l

0.20

371

2593

Acute alcohol intoxication, ICD10

640

1.33

1.80

1.2

1.3

789.95

370.88

u/l

1.05

615

Cholecystectomy

335

2508

1.15

1.80

1.3

368.16

491.72

u/l

0.98

309

2381

Chronic laryngitis and laryngotracheitis

480

1.38

1.75

1.4

1.3

382.90

340.81

u/l

0.33

460

Other and unspecified disorders of vitreous body

131

1606

0.80

1.75

1.3

393.10

482.99

u/l

0.63

124

1529

Soft tissue disorders related to use, overuse and pressure

122

969

1.26

1.74

1.4

1.3

732.02

516.90

u/l

0.23

115

924

Presence of other devices

134

1072

1.25

1.73

1.4

1.3

297.22

525.49

u/l

2.24

127

1013

Dissocial personality disorder

2.94

1.72

1.4

1.3

1007.86

297.96

u/l

—

Other/unspecified mastoiditis and related conditions

3.92

1.72

1.0

1.2

239.20

319.51

u/l

—

Benign neoplasm: Ill-defined sites within the digestive system

3.91

1.72

1.0

1.1

329.00

299.02

u/l

—

Follow-up examination after treatment for conditions other than malignant neoplasms

178

971

1.21

1.71

1.3

820.78

537.19

u/l

0.44

168

918

Alzheimer’s disease (Late onset)

109

1160

0.79

1.70

1.3

438.04

370.07

u/l

0.19

1093

Otitis externa

673

1.31

1.69

1.3

578.08

358.44

u/l

0.65

641

Horner syndrome

2.83

1.65

1.6

1.3

438.00

353.33

u/l

—

Tonsillectomy and adenotomy

748

0.76

1.65

1.3

511.56

458.47

u/l

0.25

716

Other and unspecified medical devices associated with adverse incidents

3.64

1.62

1.0

1.1

325.20

223.24

u/l

—

Myocardial infarction, unclassifiable

155

1138

1.22

1.61

1.3

262.26

416.16

u/l

2.30

141

1065

Budesonide

312

1.45

1.58

1.4

1.3

219.84

347.39

u/l

2.40

298

Polycystic ovarian syndrome, consortium definition

190

941

1.20

1.57

1.4

1.2

302.13

408.03

u/l

1.72

173

895

Other/unspecified dorsalgia

161

1323

1.21

1.57

1.4

1.3

367.44

535.85

u/l

1.43

154

1266

Benign neoplasm: Rectum

754

1.28

1.54

1.5

1.3

983.52

352.04

u/l

0.45

714

Alzheimer’s disease (undefined)

0.00

1.53

0.0

1.2

—

272.45

—

Combinations of oral blood glucose lowering drugs

139

1140

1.22

1.52

1.4

1.3

257.57

555.67

u/l

3.36

131

1084

Bullous keratopathy

2.63

1.52

1.0

1.6

288.29

246.68

u/l

—

Abnormal serum enzyme levels

181

1484

1.19

1.52

1.3

392.29

554.94

u/l

0.96

171

1413

Benign neoplasm: Caecum

418

1.37

1.49

1.4

240.89

323.59

u/l

1.21

400

Episodal and paroxysmal disorders

486

2221

1.11

1.47

1.3

331.46

514.77

u/l

4.01

448

2103

Acute upper respiratory infections

474

2625

1.11

1.46

1.4

1.3

422.89

493.37

u/l

0.68

449

2481

Melanocytic naevi

107

860

1.25

1.43

1.4

1.3

348.68

382.79

u/l

0.31

815

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

139

1327

0.83

1.42

1.4

1.3

316.16

470.21

u/l

1.71

132

1261

Myocardial infarction, with ST-elevation

112

907

1.24

1.41

1.4

1.3

465.82

372.88

u/l

0.29

106

854

Benign neoplasm: Skin of other and unspecified parts of face

371

1.38

1.41

1.2

1.4

307.03

326.60

u/l

0.14

356

Anxiety disorders, excluding more controls

310

1773

1.14

1.41

1.3

628.16

446.11

u/l

0.76

290

1690

Hyperplasia of prostate

233

1139

1.16

1.40

1.4

1.3

376.36

623.54

u/l

1.98

219

1092

Spinal stenosis

280

1861

1.14

1.39

1.4

1.3

422.04

483.26

u/l

0.31

266

1770

Other predominantly sexually transmitted diseases, not elsewhere classified

246

1.47

1.39

1.2

1.3

423.96

394.98

u/l

0.11

235

Listeriosis

3.00

1.37

1.4

222.20

255.55

u/l

—

Abnormality of red blood cells

2.99

1.36

1.6

1.3

136.40

215.04

u/l

—

All anxiety disorders

174

1163

1.18

1.36

1.3

704.07

429.90

u/l

1.01

164

1110

Iridocyclitis

732

1.26

1.36

1.3

386.98

374.93

u/l

0.08

697

Hypothyroidism, other/unspecified

388

2282

1.12

1.35

1.3

442.73

497.02

u/l

0.17

366

2158

Any dementia

199

1608

0.86

1.34

1.2

1.3

420.92

440.70

u/l

0.07

184

1518

Urticaria and erythema

117

959

1.22

1.33

1.3

497.24

365.98

u/l

1.11

108

913

Other predominantly sexually transmitted diseases, not elsewhere classified

216

1.48

1.32

1.2

1.3

447.89

379.17

u/l

0.25

205

Other dorsopathies, not elsewhere classified

440

2073

1.11

1.32

1.3

417.41

497.78

u/l

0.62

414

1966

Combined immunodeficiencies

2.52

1.31

1.8

1.3

230.72

270.36

u/l

—

Chronic hepatitis NAS

2.52

1.30

1.3

85.50

295.10

u/l

—

Unspecified mental disorder

133

1107

1.20

1.30

1.2

1.3

544.76

387.14

u/l

2.32

125

1057

Impaction of intestines

2.81

1.29

1.0

1.2

142.00

355.22

u/l

—

Seborrhoeic dermatitis

318

1.39

1.28

1.3

335.36

342.49

u/l

0.05

303

Alcohol abuse, main dg

456

1.32

1.28

1.2

1.4

633.22

391.74

u/l

0.87

438

Degenerative diseases of the nervous system

181

1549

0.86

1.26

1.2

1.3

553.59

440.35

u/l

0.35

163

1461

Subjective visual disturbances

794

1.24

1.26

1.4

1.3

279.72

392.22

u/l

2.09

752

Additional codes for the location of defect, injury or illness

146

1.58

1.26

1.5

1.3

561.81

357.94

u/l

0.52

141

Alcohol induced polyneuropathy

2.25

1.25

1.3

299.88

280.20

u/l

—

Other and unspecified pemphigoid

2.43

1.25

2.0

1.4

325.17

333.84

u/l

—

Unspecified chronic bronchitis

115

1.66

1.25

1.6

1.3

509.74

329.01

u/l

0.57

108

Other bacterial agents as the cause of diseases classified to other chapters

2.42

1.25

2.7

1.2

197.50

309.53

u/l

—

Myalgia

634

1.26

1.25

1.4

1.3

392.79

455.91

u/l

0.30

602

Coxarthrosis

261

1514

1.14

1.25

1.4

1.3

338.64

525.84

u/l

1.51

246

1440

Disorders of ocular muscles, binocular movement, accommodation and refraction

154

1294

1.18

1.24

1.4

1.3

607.35

412.21

u/l

0.57

143

1224

Other hearing loss

165

1378

1.17

1.23

1.3

434.59

472.42

u/l

0.13

157

1301

Anterior Iridocyclitis

627

1.26

1.22

1.3

381.67

360.98

u/l

0.19

600

Kela-code for severe mental illness

122

1015

1.20

1.22

1.2

1.3

566.29

371.93

u/l

3.13

114

969

Habit and impulse disorders

2.64

1.22

1.2

698.02

448.93

u/l

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

2.33

1.19

1.2

1.3

274.97

287.72

u/l

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

401

2378

1.11

1.18

1.3

438.50

490.95

u/l

0.17

379

2253

Polymyalgia rheumatica

551

1.27

1.17

1.1

1.3

783.14

306.30

u/l

1.01

518

Diseases of inner ear

198

2196

0.87

1.17

1.3

362.28

497.47

u/l

1.40

188

2082

Hypopituitarism

149

1.55

1.17

1.2

1.4

451.35

369.16

u/l

0.41

143

Melanoma in situ of upper limb, including shoulder

2.53

1.15

1.2

1.4

394.00

327.21

u/l

—

Orchitis and epididymitis

395

1.32

1.14

1.3

400.02

462.61

u/l

0.25

380

Oral lichen planus, including avohilmo , including avohilmo

153

0.52

1.14

1.6

1.3

328.76

315.94

u/l

—

147

Disorders of sclera, cornea, iris and ciliary body

216

1896

1.14

1.13

1.4

1.3

370.46

544.00

u/l

1.88

200

1798

Melanoma of uvea

2.36

1.13

1.7

1.3

179.14

324.78

u/l

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

355

2162

1.11

1.12

1.3

468.36

492.94

u/l

0.06

336

2051

Varicose veins

298

2012

1.12

1.4

1.3

377.77

482.39

u/l

0.82

282

1905

Benign paroxysmal vertigo

1097

0.82

1.11

1.5

1.3

329.90

360.65

u/l

0.21

1036

Other strabismus

493

1.27

1.09

1.4

1.3

763.23

370.35

u/l

0.69

475

Inflammatory bowel disease

112

939

1.19

1.07

1.4

1.3

307.59

381.41

u/l

1.12

107

894

Benign neoplasm: Oesophagus

2.14

1.06

1.1

1.4

339.00

296.34

u/l

—

Other abnormal uterine and vaginal bleeding

444

1.24

1.05

1.3

1.2

190.36

362.68

u/l

3.01

422

Folate deficiency anaemia

2.29

1.03

1.2

1.6

111.00

383.47

u/l

—

Dorsopathies

446

2074

1.09

1.03

1.3

374.49

497.58

u/l

1.65

416

1967

Visual disturbances

200

1763

1.14

1.01

1.3

298.21

513.82

u/l

3.26

188

1670

Congenital malformations of great arteries

2.24

1.01

2.0

1.2

364.40

368.12

u/l

—

Acute alcohol intoxication

115

974

1.18

1.00

1.2

1.3

685.87

453.65

u/l

0.64

105

928

Other neurotic disorders

123

1.55

0.99

1.4

1.3

592.99

336.17

u/l

0.80

117

Otosclerosis

237

0.63

0.99

1.3

1.4

301.27

328.48

u/l

0.13

231

Traction detachment of retina

2.19

0.98

1.2

1.3

205.60

283.10

u/l

—

Hallux valgus (acquired)

101

865

0.84

0.98

1.4

1.3

351.59

415.26

u/l

0.58

824

Polyuria

111

939

1.18

0.98

1.5

1.3

418.41

455.50

u/l

0.15

103

892

Diseases of salivary glands

115

976

1.18

0.98

1.3

413.35

390.46

u/l

0.15

107

927

Use of entacapone

0.00

0.98

0.0

1.4

—

267.71

—

Parkinson's disease, strict definition

704

0.79

0.96

1.3

310.53

338.20

u/l

0.17

664

Conjunctivitis (acute, non atopic)

737

1.20

0.95

1.3

396.54

370.10

u/l

0.17

696

Pruritus

293

1.33

0.95

1.3

284.95

318.67

u/l

0.23

284

Ventral hernia

106

896

1.18

0.95

1.4

1.3

321.97

464.84

u/l

0.96

100

845

Type 1 diabetes, definitions combined

108

1.57

0.95

1.1

1.2

328.12

417.37

u/l

0.37

103

Glaucoma

299

2331

1.10

0.94

1.3

471.01

477.25

u/l

0.02

276

2210

Neurotic, stress-related and somatoform disorders

310

1966

1.10

0.94

1.3

639.80

495.56

u/l

0.55

289

1869

Other injuries of upper limb, level unspecified

2.24

0.93

1.5

1.2

193.83

268.80

u/l

—

Maternal care for known or suspected abnormality of pelvic organs

168

0.65

0.93

1.2

1.3

316.56

394.40

u/l

0.45

158

Cystitis

321

2097

0.91

0.92

1.4

1.3

331.39

494.44

u/l

2.32

306

1988

Recurrent aphthous stomatitis , including avohilmo

383

1.28

0.92

1.3

1.4

473.12

336.01

u/l

0.53

369

Artificial joint operation, meniscal resection

382

2701

0.92

0.91

1.4

1.3

451.07

485.57

u/l

0.21

367

2551

severe traumatic brain injury, does not include concussion

123

1057

1.17

0.91

1.3

355.81

448.02

u/l

0.56

118

997

Fracture of skull and facial bones

653

1.21

0.91

1.2

1.3

815.89

398.68

u/l

0.62

629

Inguinal or femoral hernia, bilateral

518

1.24

0.90

1.5

1.3

319.33

405.16

u/l

0.47

489

Other bacterial agents as the cause of diseases classified to other chapters

2.08

0.89

2.7

1.3

197.50

321.91

u/l

—

Caught, crushed, jammed or pinched in or between objects

104

0.48

0.89

1.0

1.3

121.40

358.23

u/l

—

Disorders of lacrimal system

172

1516

1.13

0.87

1.3

334.61

407.46

u/l

0.99

162

1433

Leiomyoma of uterus

177

884

1.14

0.87

1.3

291.59

401.08

u/l

1.65

164

836

Type 1 diabetes, strict (exclude DM2)

111

1.53

0.86

1.1

1.2

328.12

412.60

u/l

0.34

106

Lower back pain or/and sciatica

453

2740

1.08

0.86

1.3

473.51

493.38

u/l

0.11

424

2595

Gonarthrosis,primary

391

2612

0.92

0.86

1.3

398.32

498.90

u/l

1.29

375

2463

Diseases of male genital organs

270

1231

1.11

0.86

1.4

1.3

338.62

642.33

u/l

3.35

254

1178

Inguinal hernia, bilateral

513

1.23

0.86

1.5

1.3

322.74

405.79

u/l

0.44

484

Disorders of refraction and accommodation

601

1.21

0.85

1.4

1.3

294.56

383.44

u/l

1.31

575

Acute and subacute iridocyclitis

586

1.21

0.85

1.3

355.20

367.39

u/l

0.10

563

Prolapse and hernia of ovary and fallopian tube

136

0.58

0.83

1.1

1.2

186.83

250.44

u/l

—

129

Other disorders of lacrimal gland

135

1180

1.15

0.82

1.4

1.3

300.60

397.83

u/l

1.74

127

1114

Anxiety disorders

314

2001

1.09

0.82

1.3

635.39

493.51

u/l

0.55

293

1901

Disorders of vestibular function (Vertigo)

169

1870

0.89

0.82

1.4

1.3

389.16

474.55

u/l

0.65

160

1773

Chondropathies

372

1.27

0.82

1.4

1.3

334.33

355.09

u/l

0.14

362

Traumatic ischaemia of muscle

1.89

0.82

1.0

1.3

4359.50

269.76

u/l

—

Pain in joint

234

1345

1.11

0.82

1.4

1.3

443.39

584.41

u/l

0.98

218

1277

Erectile dysfunction

436

1.24

0.81

1.2

1.4

263.29

361.21

u/l

1.11

415

Any dementia, excluding more controls

186

1431

0.89

0.80

1.2

1.3

409.24

420.10

u/l

0.04

174

1365

Endometriosis diagnosis and infertility diagnosis occurring together

114

1.49

0.79

1.2

1.3

358.62

404.76

u/l

0.33

108

Injury of muscle and tendon at shoulder and upper arm level

129

1471

0.88

0.79

1.3

418.67

515.22

u/l

0.77

123

1401

Arthrosis

321

1615

1.09

0.78

1.3

488.45

538.63

u/l

0.14

304

1537

Alzheimer’s disease (Late onset), excluding more controls

572

0.83

0.78

1.3

484.79

408.76

u/l

0.14

551

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

0.00

0.78

0.0

1.2

—

249.36

—

Alzheimer disease, excluding more controls

646

0.85

0.78

1.2

1.3

520.76

403.96

u/l

0.26

621

Wet age-related macular degeneration

107

897

1.16

0.77

1.2

1.3

519.18

379.84

u/l

0.34

100

842

Haemorrhoids and perianal venous thrombosis

147

1298

1.13

0.76

1.3

337.07

546.00

u/l

1.93

139

1236

Benign lipomatous neoplasm

1060

0.86

0.75

1.3

415.94

373.73

u/l

0.23

1006

Headache

196

1408

1.11

0.75

1.4

1.3

320.92

544.30

u/l

2.54

185

1344

Crohn's disease of large intestine

1.54

0.75

1.5

1.3

183.29

347.16

u/l

2.48

Sleep disorders (combined)

501

2459

1.07

0.74

1.3

500.00

488.83

u/l

0.03

471

2330

Parkinson's disease

745

0.83

0.74

1.3

322.14

335.95

u/l

0.09

703

Monoplegia

1.85

0.73

1.1

1.3

152.29

291.30

u/l

—

Disorders of synovium and tendon

166

1624

0.89

0.73

1.4

1.3

486.16

521.88

u/l

0.14

158

1537

Excessive attrition of teeth

144

1621

0.89

0.73

1.3

386.40

536.63

u/l

1.37

136

1549

Other diseases of hard tissues of teeth

301

1429

1.09

0.73

1.4

1.3

299.95

428.15

u/l

2.41

288

1348

Neuromuscular dysfunction of bladder

316

1.27

0.73

1.2

1.4

340.74

346.50

u/l

0.03

303

Benign neoplasm of mouth and pharynx

343

1.26

0.73

1.2

1.4

259.22

323.08

u/l

0.58

330

Deep bite

150

0.64

0.71

1.2

1.3

443.82

373.35

u/l

0.22

142

Other headache syndromes

108

1234

0.87

0.71

1.3

390.88

459.78

u/l

0.35

100

1182

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

134

1.42

0.71

1.5

1.3

683.11

343.19

u/l

0.83

129

Other symptoms and signs involving the nervous and musculoskeletal systems

160

1433

1.12

0.70

1.3

674.99

507.04

u/l

0.24

150

1361

Keratitis

129

1142

1.13

0.69

1.3

361.90

395.96

u/l

0.24

120

1083

Benign neoplasm of brain and other parts of central nervous system

181

0.66

0.69

1.1

1.4

954.37

345.93

u/l

0.84

176

Dermatophytosis

245

2244

1.09

0.68

1.3

649.17

498.75

u/l

0.24

232

2138

Transport accidents

160

1234

1.12

0.68

1.3

679.99

470.11

u/l

0.32

152

1172

Other specific joint derangements/joint disorders

264

1566

1.09

0.68

1.4

1.3

442.46

550.74

u/l

0.80

248

1492

Striking against or struck by other objects

109

955

1.14

0.67

1.3

639.15

393.56

u/l

0.85

915

Migraine without aura and triptan purchases

180

0.67

1.5

1.3

347.86

383.81

u/l

0.18

172

Fracture at wrist and hand level

120

1059

1.13

0.66

1.3

853.90

426.15

u/l

0.56

112

1004

Pneumoconiosis due to asbestos and other mineral fibres

111

1.45

0.66

1.4

367.54

324.54

u/l

0.15

106

Disturbances of skin sensation

697

1.16

0.65

1.4

1.3

535.72

371.64

u/l

1.15

663

Primary hyperparathyroidism

313

1.25

0.65

1.3

221.67

304.56

u/l

0.89

300

Maternal care for other conditions predominantly related to pregnancy

186

0.68

0.64

1.5

1.3

401.61

431.20

u/l

0.10

173

Leukaemia of unspecified cell type

1.73

0.64

2.0

1.3

188.20

327.80

u/l

—

Somatoform disorder

377

1.22

0.63

1.3

1.4

1037.07

355.30

u/l

0.60

366

Maternal care for known or suspected malpresentation of fetus

100

0.65

0.62

1.1

1.3

661.89

433.73

u/l

—

Localized swelling, mass and lump of skin and subcutaneous tissue

124

1107

1.12

0.60

1.3

330.32

386.96

u/l

0.58

113

1049

Other or unspecified paralytic strabismus

0.00

0.60

0.0

1.3

—

271.40

—

Gonarthrosis [arthrosis of knee](FG)

340

1844

1.07

0.60

1.3

408.47

535.25

u/l

1.24

324

1742

Overjet

0.00

0.60

0.0

1.3

—

424.80

—

Ulcerative colitis, NAS

353

1.22

0.59

1.3

1.4

356.23

369.08

u/l

0.07

340

Persons encountering health services in circumstances related to reproduction

120

906

0.89

0.59

1.3

345.04

515.35

u/l

2.46

113

862

Urticaria

705

1.15

0.58

1.3

470.70

356.50

u/l

0.79

667

Oxicams

109

698

0.89

0.58

1.3

366.05

558.20

u/l

0.89

100

660

Dermatographic urticaria

115

0.61

0.57

1.3

483.41

347.74

u/l

—

110

Other disorders of eyelid

223

1958

1.08

0.57

1.3

304.20

469.51

u/l

2.02

211

1853

Dislocation, sprain and strain of joints and ligaments of knee

154

1561

0.91

0.56

1.3

577.06

524.11

u/l

0.15

144

1495

Other joint disorders

337

1662

1.07

0.56

1.4

1.3

373.87

542.92

u/l

1.95

314

1581

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

148

0.67

0.55

1.6

1.3

408.80

311.19

u/l

—

143

Strabismus

717

1.14

0.55

1.4

1.3

884.76

359.62

u/l

0.97

682

Migraine with aura and triptan purchases

194

0.72

0.54

1.5

1.3

258.02

350.73

u/l

0.92

184

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.58

0.54

1.2

1.3

234.50

316.48

u/l

—

Viral warts

506

1.17

0.53

1.4

1.3

354.60

364.87

u/l

0.07

488

Parkinson's disease, including avohilmo

770

0.87

0.52

1.3

317.56

338.36

u/l

0.15

726

Deforming dorsopathies

884

1.12

0.51

1.4

1.3

813.11

402.68

u/l

0.87

851

Single delivery by forceps and vacuum extractor

0.68

0.50

1.1

1.3

386.20

481.45

u/l

—

Pedal cyclist injured in noncollision transport accidents

269

0.78

0.50

1.4

2561.67

361.72

u/l

0.51

258

Contact with nonpowered hand tool

108

0.65

0.48

1.4

1.5

735.43

322.45

u/l

—

103

Disorders of conjunctiva

261

2236

0.94

0.48

1.4

1.3

403.49

532.82

u/l

1.47

246

2118

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

1.40

0.48

1.7

1.3

519.84

353.59

u/l

0.39

Gonarthrosis

296

1583

1.07

0.48

1.3

414.01

522.25

u/l

0.90

280

1507

Other enthesopathies

101

909

1.11

0.47

1.6

1.3

335.54

438.03

u/l

1.39

870

Diseases of middle ear and mastoid

174

1314

1.08

0.46

1.3

501.09

512.64

u/l

0.03

167

1243

Other intervertebral disc disorders

358

2038

1.06

0.46

1.3

417.61

499.55

u/l

0.54

337

1934

Unspecified urinary incontinence

255

1.22

0.45

1.5

1.3

545.49

309.86

u/l

0.36

247

Other problems related to primary support group, including family circumstances

143

1.29

0.45

1.1

1.4

597.68

352.73

u/l

1.06

136

Rotator cuff syndrome

276

1863

1.06

0.44

1.3

400.37

499.15

u/l

0.95

259

1765

Other degenerative diseases of the nervous system

137

939

1.09

0.43

1.2

1.3

946.07

466.74

u/l

0.66

128

902

Inhalation and ingestion of food causing obstruction of respiratory tract

1.62

0.43

1.6

1.3

277.00

328.30

u/l

—

Vasomotor and allergic rhinitis

917

0.90

0.42

1.4

1.3

865.76

409.75

u/l

0.57

873

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

0.66

0.42

1.3

222.50

289.88

u/l

—

Cutis laxa senilis

0.00

0.41

0.0

1.1

—

298.75

—

Frontotemporal dementia

0.00

0.41

0.0

1.4

—

327.64

—

Autism spe

0.00

0.41

0.0

1.1

—

486.07

—

Female infertility

304

0.86

0.41

1.1

1.3

732.49

464.68

u/l

0.29

291

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.41

0.0

1.3

—

340.63

—

Frontotemporal dementia, wide, incl. Pick's disease

0.00

0.40

0.0

1.7

—

317.18

—

Early lumbar disc prolapse operation

141

1.28

0.40

1.3

615.50

395.74

u/l

0.62

135

Mood [affective] disorders

365

2482

0.95

0.40

1.3

628.89

492.83

u/l

0.68

342

2354

Premature rupture of membranes

139

0.77

0.39

1.1

1.3

591.79

406.12

u/l

0.44

130

Benign neoplasm: Eye, unspecified

0.00

0.39

0.0

1.4

—

235.77

—

Hereditary motor and sensory neuropathy

0.00

0.39

0.0

1.4

—

203.35

—

Chronic sinusitis

151

1401

1.08

0.39

1.5

1.3

522.32

550.31

u/l

0.09

141

1337

Oter anti-inflammatory and antirheumatic agents, non-steroids

135

687

1.09

0.38

1.4

1.3

307.19

560.18

u/l

1.39

129

650

Organic, including symptomatic, mental disorders

289

1953

1.05

0.37

1.2

1.3

501.42

429.85

u/l

0.27

273

1856

Fibromyalgia

157

0.76

0.35

1.4

1.2

545.00

331.90

u/l

0.44

151

Haemorrhage in early pregnancy

406

0.86

0.35

1.2

1.3

592.28

420.51

u/l

0.70

383

Blepharochalasis

130

1207

1.08

0.35

1.3

366.89

453.36

u/l

0.44

123

1136

Other appendicitis

199

1.21

0.35

1.8

1.4

290.00

356.77

u/l

0.50

192

Acetic acid derivatives and related substances

147

710

1.08

0.34

1.3

601.76

558.08

u/l

0.05

137

671

Alzheimer’s disease (Atypical or mixed)

548

0.89

0.34

1.3

418.81

347.26

u/l

0.26

516

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

130

1356

0.93

0.33

1.4

1.3

443.87

395.03

u/l

0.39

123

1287

Seborrhoeic keratosis

902

1.09

0.33

1.4

1.3

569.76

375.08

u/l

0.47

853

Hypermetropia

145

1.24

0.33

1.4

1.3

181.93

359.01

u/l

3.84

139

Acute appendicitis, no complications

155

1645

0.94

0.33

1.3

436.48

589.52

u/l

1.17

149

1559

Nontraumatic intracranial haemmorrhage

902

1.09

0.33

1.3

394.94

412.25

u/l

0.08

852

Recurrent or chronic depression

711

0.92

0.32

1.3

814.95

421.67

u/l

0.70

680

Mood disorders

369

2486

0.96

0.32

1.3

625.29

492.88

u/l

0.67

346

2358

Glaucoma, exfoliation

483

1.12

0.32

1.3

1075.91

316.80

u/l

0.70

455

Other diseases of upper respiratory tract

502

2525

1.04

0.31

1.4

1.3

459.92

485.86

u/l

0.16

474

2394

Parkinson's disease, strict definition, excluding more controls

593

0.90

0.31

1.3

310.53

409.62

u/l

0.54

569

Injuries to the wrist and hand

369

2659

0.96

0.31

1.3

576.32

478.36

u/l

0.25

352

2510

Coxarthrosis, primary, with hip surgery

223

2194

0.95

0.31

1.4

1.3

338.36

486.16

u/l

1.13

211

2075

Conjunctivitis

219

1924

0.95

0.31

1.3

430.50

457.34

u/l

0.19

206

1822

Lichen sclerosus et atrophicus

240

0.83

0.30

1.7

1.3

355.63

312.99

u/l

0.19

229

Coxibs

144

710

1.07

0.30

1.3

293.35

558.08

u/l

1.57

135

671

Postprocedural disorders of nervous system

102

1.28

0.30

1.2

1.3

445.76

334.59

u/l

0.38

Synovial cyst of popliteal space [Baker]

231

1.17

0.29

1.4

1329.17

306.01

u/l

0.57

223

Prolonged pregnancy

1.26

0.29

1.3

709.29

390.96

u/l

0.77

Extrapyramidal and movement disorders

156

1653

0.94

0.29

1.3

359.91

485.16

u/l

1.17

145

1569

Allergic conjunctivitis

136

1408

0.94

0.28

1.4

1.3

440.50

399.31

u/l

0.33

129

1338

Polyp of the female genital tract

469

0.92

0.27

1.4

1.2

478.22

391.27

u/l

0.38

444

Impingement syndrome of shoulder

854

1.08

0.27

1.3

312.80

574.74

u/l

2.12

815

Mood disorders, excluding more controls

364

2095

1.04

0.27

1.3

620.77

440.89

u/l

1.03

341

1997

Maternal care for other known or suspected fetal problems

116

0.82

0.26

1.7

1.2

288.73

448.78

u/l

1.16

110

Memory loss

367

1.12

0.26

1.3

1.4

682.47

302.83

u/l

0.51

349

Alzheimer’s disease (Atypical or mixed), excluding more controls

414

0.90

0.26

1.2

1.3

435.34

433.74

u/l

0.00

400

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

955

0.93

0.25

1.4

1.3

476.34

407.28

u/l

0.21

911

Postpartum haemorrhage

207

0.85

0.25

1.2

1.3

305.00

439.58

u/l

1.56

197

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

143

0.84

0.25

1.3

335.63

441.11

u/l

0.55

136

Necrosis of pulp, including avohilmo

162

1700

0.95

0.25

1.3

566.85

548.43

u/l

0.04

157

1615

Other disorders of cornea

282

1.14

0.25

1.2

1.4

480.15

318.31

u/l

0.36

274

Female infertility, cervical, vaginal, other or unspecified origin

297

0.90

0.25

1.1

1.3

769.74

466.26

u/l

0.32

284

Other obstetric conditions, not elsewhere classified

149

0.85

0.24

1.3

484.60

444.43

u/l

0.09

142

Noninflammatory disorders of female genital tract

484

0.93

0.23

1.3

1.2

337.83

394.06

u/l

0.44

458

Disorders of breast

116

994

1.06

0.23

1.2

1.3

403.53

387.84

u/l

0.09

108

942

Primary open-angle glaucoma, strict

133

1259

1.05

0.23

1.3

421.92

391.76

u/l

0.08

124

1186

Diseases of the ear and mastoid process

475

2319

1.03

0.22

1.3

528.68

501.74

u/l

0.09

452

2194

Deviated nasal septum

122

1285

0.95

0.22

1.4

1.3

613.40

548.66

u/l

0.18

113

1228

Allergic rhinitis

559

0.92

0.21

1.3

1205.64

393.05

u/l

0.65

539

Other sudden death, cause unknown

0.00

0.21

0.0

1.5

—

146.09

—

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

0.00

0.21

0.0

1.5

—

144.33

—

Carcinoma in situ of oral cavity

0.00

0.21

0.0

1.2

—

150.78

—

Oesophagitis, drug-induced

0.00

0.21

0.0

1.4

—

200.50

—

Bradycardia, unspecified, drug-induced

0.00

0.21

0.0

1.3

—

232.42

—

Sequelae of inflammatory diseases of the central nervous system

0.00

0.21

0.0

1.3

—

203.07

—

Foreign object accidentally left in body during surgical and medical care

0.00

0.21

0.0

1.1

—

206.43

—

Melanoma in situ, other sites/unspecified

0.00

0.21

0.0

1.3

—

148.16

—

Other and unspecified pemphigus

0.00

0.21

0.0

1.4

—

244.67

—

Other cestode infections

0.00

0.21

0.0

1.1

—

202.33

—

Generalized pustular psoriasis

0.00

0.21

0.0

1.4

—

189.50

—

Injury of nerves at hip and thigh level

0.00

0.21

0.0

1.4

—

128.97

—

Use of riluzole

0.00

0.21

0.0

1.4

—

203.07

—

Benign neoplasm: Scrotum

0.00

0.21

0.0

1.5

—

184.55

—

Vaginal lichen planus

0.00

0.21

0.0

1.2

—

226.43

—

Fatigue fracture of vertebra

0.00

0.21

0.0

1.2

—

157.00

—

Accidental poisoning by and exposure to other gases and vapours

0.00

0.21

0.0

1.3

—

183.94

—

Postinfectious hypothyroidism

0.00

0.21

0.0

1.1

—

161.76

—

Other and unspecified papulosquamous disorders

0.00

0.21

0.0

1.4

—

152.79

—

Follicular adenocarcinoma of thyroid gland

0.00

0.21

0.0

1.2

—

384.73

—

Other and unspecified injuries of forearm

0.00

0.21

0.0

1.4

—

160.36

—

Undefined dementia

578

0.92

0.21

1.1

1.3

611.15

364.32

u/l

0.44

539

Disorders of puberty, all

0.00

0.21

0.0

1.2

—

506.87

—

Other and unspecified neuropathies

0.00

0.21

0.0

1.4

—

227.72

—

Ankylosis of joint

0.00

0.21

0.0

1.1

—

231.31

—

Other disorders following mastoidectomy

0.00

0.21

0.0

1.1

—

201.05

—

Senile degeneration of the brain, not elsewhere classified

0.00

0.21

0.0

1.4

—

342.62

—

Occupant of special vehicle mainly used on industrial premises injured in transport accident

0.00

0.21

0.0

1.4

—

372.08

—

Other extrapyramidal and movement disorders in other diseases

894

0.94

0.21

1.3

417.31

350.05

u/l

0.48

846

Pedal cyclist injured in collision with pedestrian or animal

0.00

0.21

0.0

1.5

—

408.33

—

Meniscus derangement

219

1532

0.96

0.21

1.3

465.96

529.09

u/l

0.24

205

1460

Urolithiasis

141

1477

0.95

0.20

1.4

1.3

411.76

555.14

u/l

0.59

132

1406

Simple and mucopurulent chronic bronchitis

145

1.17

0.20

2.1

1.3

464.94

310.86

u/l

0.24

138

Idiopathic peripheral autonomic neuropathy

0.00

0.20

0.0

1.3

—

156.19

—

UC patients in KELA-register (code 208), prior to 1994

123

0.81

0.20

1.2

1.3

314.10

349.67

u/l

—

116

Adrenogenital disorders

0.00

0.20

0.0

1.4

—

203.86

—

Disorder of pancreatic internal secretion, other and/or unspecified

0.00

0.20

0.0

1.4

—

285.38

—

Perineal laceration during delivery

0.81

0.20

1.3

366.89

399.75

u/l

—

Depression or dysthymia

289

1544

1.03

0.20

1.4

1.3

514.43

466.67

u/l

0.20

271

1472

Cervical disc disorders

134

1404

0.95

0.20

1.4

1.3

422.90

539.16

u/l

0.71

127

1340

Primary open-angle glaucoma

166

1540

1.04

0.19

1.3

541.37

426.57

u/l

0.25

153

1453

Selective serotonin reuptake inhibitors

431

2193

1.03

0.19

1.3

604.76

455.56

u/l

0.60

406

2082

Spondylosis

239

1885

1.03

0.18

1.3

539.49

485.38

u/l

0.22

224

1793

Artrosis, including avohilmo

361

2028

0.97

0.18

1.3

478.39

514.28

u/l

0.11

343

1923

LSIL lesion of the cervix uteri

121

0.83

0.18

1.2

1.3

200.47

406.19

u/l

—

116

Acute appendicitis

243

2202

1.03

0.17

1.4

1.3

390.82

557.39

u/l

2.05

233

2088

Parkinson's disease, excluding more controls

622

0.94

0.17

1.3

322.14

409.14

u/l

0.50

598

Bicipital tendinitis

120

0.83

0.16

1.1

1.4

333.08

307.64

u/l

—

115

Antepartum haemorrhage, not elsewhere classified

1.18

0.16

1.0

1.3

506.75

400.99

u/l

—

Inflammatory diseases of prostate (prostatitis)

602

1.06

0.16

1.4

1.3

280.94

651.46

u/l

2.24

582

Excessive earwax

242

2293

1.03

0.16

1.3

347.39

502.54

u/l

2.00

228

2173

Other hammer toe(s) (acquired)

607

0.94

0.15

1.4

1.3

394.37

377.84

u/l

0.07

577

Ulcerative proctitis

130

1.15

0.15

1.5

1.4

251.47

323.16

u/l

0.36

125

Medical treatment for female infertility

167

1.13

0.15

1.2

1.3

1280.46

445.95

u/l

0.44

157

Diseases of tongue

197

1.12

0.15

1.5

1.3

294.25

346.11

u/l

0.30

190

Carcinoma in situ of cervix uteri

102

1.18

0.15

1.2

1.3

220.23

345.13

u/l

1.29

Cluster headache, wide,, including avohilmo

0.78

0.14

1.0

1.3

451.29

343.13

u/l

—

Appendicitis, broad definition

262

2312

1.02

0.14

1.4

1.3

383.90

554.41

u/l

2.31

252

2193

Pregnancy with abortive outcome

155

836

0.97

0.13

1.4

1.3

442.50

382.71

u/l

0.19

147

790

Endometriosis

474

0.95

0.13

1.4

1.2

467.52

392.31

u/l

0.33

448

Other and/or unspecified nontoxic goitre

218

1.10

0.13

1.3

1.4

315.42

324.12

u/l

0.05

210

Sciatica+with lumbago

178

1684

0.97

0.13

1.4

1.3

412.99

515.93

u/l

0.76

168

1604

Anti-inflammatory and antirheumatic products, non-steroids

137

712

0.97

0.12

1.3

365.31

557.61

u/l

0.92

132

673

Tongue abnormality

171

1.11

0.12

1.5

1.3

280.71

322.18

u/l

0.21

165

Benign neoplasm: Other and unspecified parts of mouth

1.18

0.12

1.5

1.3

278.00

332.72

u/l

—

Diseases of appendix

264

2327

1.02

0.12

1.4

1.3

382.89

552.85

u/l

2.32

253

2208

Nontoxic single thyroid nodule

179

0.89

0.12

1.6

1.4

291.63

328.55

u/l

0.17

174

Menorrhagia

479

1.04

0.12

1.5

1.2

297.01

388.53

u/l

0.80

453

Glucosamine medication

224

1830

0.98

0.12

1.4

1.3

272.37

470.72

u/l

3.26

210

1734

Disorders of vitreous body

200

1980

0.98

0.12

1.3

354.54

497.08

u/l

1.61

191

1882

Unspecified dementia

548

0.95

0.11

1.1

1.3

611.15

365.35

u/l

0.44

517

Postpartum hemorraghe, all women as controls

226

0.91

0.11

1.2

1.3

305.00

459.14

u/l

1.93

213

Ulcerative rectosigmoiditis

192

1.09

0.10

1.3

1.4

336.19

358.92

u/l

0.12

184

Injury of muscle and tendon at hip and thigh level

260

1.08

0.10

1.7

1.4

313.13

340.35

u/l

0.14

251

Other arthrosis

221

1498

1.02

0.10

1.4

1.3

651.39

526.34

u/l

0.25

202

1426

Migraine without aura

249

0.92

0.10

1.5

1.3

480.84

377.12

u/l

0.48

242

Artificial joint re-operation

242

1.08

0.09

1.6

1.3

331.69

312.20

u/l

0.07

234

Calculus of kidney and ureter

130

1334

0.97

0.09

1.4

1.3

308.71

525.02

u/l

2.22

122

1270

Flat foot [pes planus] (acquired)

247

0.93

0.08

1.3

596.23

344.27

u/l

0.44

235

Haemorrhagic disorder due to circulating anticoagulants

0.83

0.08

1.2

1.4

162.80

301.66

u/l

—

Other secondary gonarthrosis

156

1.09

0.08

1.3

1.4

374.47

342.31

u/l

0.08

150

Acute laryngitis and tracheitis

144

1.09

0.08

1.3

446.81

400.98

u/l

0.18

137

Erosion of teeth , including avohilmo

549

1.04

0.07

1.5

1.3

404.56

375.02

u/l

0.13

528

Endovascular or surgical operations to intracerebral aneurysms

166

1.08

0.07

1.3

1.4

464.64

338.99

u/l

0.51

159

Medical abortion

155

823

1.02

0.07

1.3

412.33

385.81

u/l

0.08

149

778

Redundant prepuce, phimosis and paraphimosis

749

1.03

0.07

1.4

1.3

476.47

649.48

u/l

0.36

719

Other diseases of lip and oral mucosa

133

1303

1.02

0.07

1.3

446.06

420.53

u/l

0.19

126

1242

Macular hole

206

1.07

0.07

1.1

1.3

397.00

332.48

u/l

0.40

199

Excessive vomiting in pregnancy

0.89

0.06

1.4

1.3

395.38

371.04

u/l

—

Postpartum haemorrhage due to retained placenta

0.84

0.06

1.3

1.4

327.25

407.46

u/l

—

Lumbar disc prolapse

241

1873

0.99

0.06

1.4

1.3

388.76

513.03

u/l

1.27

229

1783

Irritable bowel syndrome

730

0.97

0.06

1.4

1.3

320.89

398.69

u/l

0.77

699

Carpal tunnel syndrome

225

2010

0.99

0.06

1.4

1.3

367.77

548.26

u/l

1.57

209

1912

Glaucoma suspect

155

1524

1.02

0.06

1.3

390.51

438.45

u/l

0.14

146

1442

Hallux rigidus

497

0.97

0.06

1.4

1.3

353.92

400.15

u/l

0.31

477

Excessive, frequent and irregular menstruation

483

0.98

0.06

1.4

1.2

318.06

392.88

u/l

0.63

457

Supervision of high-risk pregnancy

113

1.06

0.05

1.2

357.40

410.91

u/l

0.18

104

Supervision of normal pregnancy

113

1.06

0.05

1.1

1.2

255.38

418.18

u/l

2.26

104

Mixed and other personality disorders

120

1.08

0.04

1.2

1.4

3778.01

366.57

u/l

0.47

112

Use of pramipexole

844

1.02

0.04

1.3

346.25

344.71

u/l

0.01

797

Depression

333

2274

0.99

0.04

1.3

639.45

499.75

u/l

0.64

313

2153

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

751

1.02

0.04

1.3

364.53

403.44

u/l

0.34

721

Tooth eruption problems

137

1.07

0.04

1.2

1.3

757.13

399.09

u/l

0.39

131

Inflammatory diseases of female pelvic organs

135

979

1.01

0.04

1.2

1.3

380.31

396.54

u/l

0.11

126

927

Other noninflammatory disorders of uterus, except cervix

442

1.02

0.03

1.2

345.62

383.39

u/l

0.13

420

Disorders of vitreous body and globe

213

2027

1.01

0.03

1.3

347.28

493.00

u/l

1.76

204

1924

Mouth breathing

141

1393

1.01

0.03

1.3

459.57

565.41

u/l

0.53

128

1333

Other specified and unspecified retinal disorders

112

1.07

0.03

1.4

1.3

119.25

338.04

u/l

5.44

107

Other acquired deformities of musculoskeletal system and connective tissue

112

1.07

0.03

1.4

390.00

316.90

u/l

0.56

107

Ménière disease

309

0.97

0.02

1.3

1.4

396.52

306.93

u/l

0.50

299

conjunctival haemorrhage

262

1.03

0.02

1.7

1.3

256.99

347.56

u/l

0.74

250

Maternal care for known or suspected fetal abnormality and damage

1.06

0.02

1.3

1.2

498.67

444.66

u/l

0.10

Internal derangement of knee

134

1323

1.01

0.01

1.4

1.3

441.05

565.60

u/l

0.37

125

1264

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

127

0.94

0.01

1.3

895.00

329.17

u/l

0.52

121

Other/unspecified disorders of vestibular function

127

0.94

0.01

1.2

1.3

196.86

296.19

u/l

1.06

122

D07AA Corticosteroids, weak (group I)

322

1.02

0.01

1.2

1.4

405.94

344.56

u/l

0.26

312

Retinal breaks without detachment

542

1.01

0.01

1.3

358.48

379.93

u/l

0.14

518

Trigger finger

403

1.02

0.01

1.4

1.3

371.59

356.47

u/l

0.08

388

Coxarthrosis, primary

293

2487

1.00

0.01

1.3

333.25

487.04

u/l

1.61

279

2350

LSIL lesion of the cervix uteri, vagina or vulva

176

0.97

0.00

1.2

1.3

218.34

392.85

u/l

2.84

169

Fall on same level involving ice and snow

206

2067

1.00

0.00

1.3

459.32

531.44

u/l

0.22

194

1965

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

655

1.01

0.00

1.4

1.3

358.60

431.99

u/l

0.46

626

Ectopic pregnancy

267

1.01

0.00

1.4

1.3

429.04

481.87

u/l

0.14

254

Postpartum hemorraghe, parous women as controls

179

1.00

0.00

1.2

1.3

305.00

419.56

u/l

1.17

172

Mucosal proctocolitis

285

1.02

0.00

1.3

1.4

308.55

385.44

u/l

0.47

273

Lateral epicondylitis

325

1.02

0.00

1.7

1.3

392.23

408.31

u/l

0.07

316

Irregular menses

603

1.00

0.00

1.4

1.3

369.99

461.96

u/l

0.61

577

Nonspecific lymphadenitis

108

1.02

0.00

1.8

1.3

230.55

337.72

u/l

0.88

102

Cervicocranial syndrome

283

0.99

0.00

1.5

1.3

495.50

314.89

u/l

1.02

271

Foreign body or object entering through skin

138

1.01

0.00

1.2

1.4

525.77

392.80

u/l

0.65

132

Antenatal screening

115

0.98

0.00

1.3

1.2

397.40

418.60

u/l

0.07

106

Other disorders of amniotic fluid and membranes

0.99

0.00

1.4

1.3

331.50

404.07

u/l

—

Calcific tendinitis of shoulder

137

1.02

0.00

1.3

1.4

251.21

315.71

u/l

0.59

132

Myotonic dystrophy (Steinert)

0.00

0.0

1.2

—

242.40

—

Fall involving playground equipment

0.00

0.0

1.3

—

226.27

—

Poikiloderma of Civatte

0.00

0.0

1.2

—

236.40

—

Reduction defects of upper limb

0.00

0.0

1.2

—

230.17

—

Whooping cough

0.00

0.0

1.2

—

200.00

—

Vitreous prolapse

0.00

0.0

1.2

—

168.34

—

Other specified/unspecified disorders of tympanic membrane

0.00

0.0

1.1

—

166.81

—

Qualitative platelet defects

0.00

0.0

1.1

—

214.34

—

Injury of blood vessels at hip and thigh level

0.00

0.0

1.4

—

248.37

—

Fibrothorax

0.00

0.0

1.1

—

316.07

—

Benign neoplasm: Central nervous system, other parts/unspecified

0.00

0.0

1.2

—

197.62

—

Colour vision deficiencies

0.00

0.0

1.1

—

223.33

—

Disorders of puberty

0.00

0.0

1.3

—

491.09

—

Hypertrophy of bone

0.00

0.0

1.0

—

210.92

—

Calcium deposit in bursa

0.00

0.0

1.1

—

184.39

—

Other and unspecified syphilis

0.00

0.0

1.3

—

201.67

—

Thyrotoxicosis factitia

0.00

0.0

1.0

—

118.12

—

Degenerative and vascular disorders of ear

0.00

-0.00

0.0

1.1

—

242.10

—

Use of pergolide

0.00

-0.00

0.0

1.6

—

129.00

—

Choroidal haemorrhage and rupture

0.00

-0.00

0.0

1.3

—

297.40

—

Phantom limb syndrome with pain

0.00

-0.00

0.0

1.4

—

178.14

—

Use of bromocriptine

0.00

-0.00

0.0

1.3

—

205.93

—

Use of trihexyphenidyl

0.00

-0.00

0.0

1.3

—

215.17

—

Juvenile Open Angle Glaucoma

0.00

-0.00

0.0

1.3

—

158.14

—

Phantom limb syndrome

0.00

-0.00

0.0

1.5

—

112.50

—

Other congenital malformations of kidney

0.00

-0.00

0.0

1.1

—

196.14

—

Familial chondrocalcinosis

0.00

-0.00

0.0

1.2

—

187.27

—

Other congenital malformations of male genital organs

0.00

-0.00

0.0

1.2

—

610.20

—

Esophageal diverticulum (pouch)

0.00

-0.00

0.0

1.7

—

408.14

—

Hypospadias

0.00

-0.00

0.0

1.4

—

614.60

—

Mastocytosis

0.00

-0.00

0.0

1.4

—

223.07

—

Other congenital malformations of male genital organs

0.00

-0.00

0.0

1.2

—

610.20

—

Toxic effect of other noxious substances eaten as food

0.00

-0.00

0.0

1.2

—

211.33

—

Injury of blood vessels at forearm level

0.00

-0.00

0.0

1.6

—

146.38

—

Toxic encephalopathy

0.00

-0.00

0.0

1.3

—

180.29

—

Osteochondrosis of ankle, juvenile

0.00

-0.00

0.0

1.2

—

224.27

—

Injury of blood vessels at neck level

0.00

-0.00

0.0

1.3

—

382.59

—

Other superficial injuries of ankle and foot

0.00

-0.00

0.0

1.3

—

192.78

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

-0.00

0.0

1.2

—

187.00

—

Superficial injury of ankle and foot, unspecified

0.00

-0.00

0.0

1.0

—

161.77

—

Accidental poisoning by and exposure to pesticides

0.00

-0.00

0.0

1.1

—

206.67

—

Discharge from other and unspecified firearms

0.00

-0.00

0.0

1.2

—

182.80

—

Contact with hypodermic needle

0.00

-0.00

0.0

1.4

—

321.00

—

Pervasive developmental disorders excl. Autism + Asperger

0.00

-0.00

0.0

1.3

—

643.33

—

Disorders in reading

0.00

-0.00

0.0

1.1

—

481.11

—

Nonadministration of surgical and medical care

0.00

-0.00

0.0

1.6

—

178.40

—

Explosion of other materials

0.00

-0.00

0.0

1.5

—

153.00

—

Exposure to ignition or melting of other clothing and apparel

0.00

-0.00

0.0

1.6

—

172.00

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

-0.00

0.0

1.1

—

203.16

—

General hospital and personal-use devices associated with adverse incidents

0.00

-0.00

0.0

1.6

—

213.00

—

Asymptomatic human immunodeficiency virus [HIV] infection status

0.00

-0.00

0.0

1.1

—

230.57

—

Diseases of thymus

0.00

-0.00

0.0

1.2

—

206.80

—

Autism spe, excluding more controls

0.00

-0.00

0.0

1.2

—

300.22

—

Pedestrian injured in collision with railway train or railway vehicle

0.00

-0.00

0.0

1.3

—

209.43

—

Pelvic region

0.00

-0.00

0.0

1.2

—

164.92

—

Precocious central puberty

0.00

-0.00

0.0

1.2

—

301.95

—

Drug-induced fever

0.00

-0.00

0.0

1.4

—

161.40

—

Duodenal ulcer - Acute with haemorrhage, drug-induced

0.00

-0.00

0.0

1.5

—

214.67

—

Benign neoplasm: Connective and other soft tissue of pelvis

0.00

-0.00

0.0

1.3

—

366.88

—

0.00

-0.00

0.0

1.1

—

205.86

—

Lymphocyte function antigen-1 [LFA-1] defect

0.00

-0.00

0.0

1.3

—

145.77

—

Disorders of muscle in diseases classified elsewhere

0.00

-0.00

0.0

1.5

—

180.12

—

Fractures involving multiple body regions

0.00

-0.00

0.0

1.3

—

230.00

—

Drug-induced aplastic anaemia

0.00

-0.00

0.0

1.2

—

135.60

—

Interstitial myositis

0.00

-0.00

0.0

1.2

—

251.34

—

Sequelae of burns, corrosions and frostbite

0.00

-0.00

0.0

1.3

—

217.48

—

Severe bullous disorders, KELA reimbursement

0.00

-0.00

0.0

1.2

—

275.94

—

Hyperalimentation, other specified

0.00

-0.00

0.0

1.2

—

141.38

—

Benign neoplasm: Urethra

0.00

-0.00

0.0

1.3

—

206.33

—

Benign neoplasm: Respiratory system, unspecified

0.00

-0.00

0.0

1.5

—

187.50

—

Thalassaemia

0.00

-0.00

0.0

1.0

—

243.71

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

-0.00

0.0

1.2

—

115.32

—

Photocontact dermatitis [berloque dermatitis]

0.00

-0.00

0.0

1.1

—

207.51

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.00

-0.00

0.0

1.2

—

980.40

—

Acanthosis nigricans

0.00

-0.00

0.0

1.2

—

176.50

—

Intentional self-harm by drowning and submersion

0.00

-0.00

0.0

1.1

—

264.57

—

Carcinoma in situ of bronchus and lung

0.00

-0.00

0.0

1.6

—

167.32

—

Familial benign pemphigus (Hailey-Hailey disease)

0.00

-0.00

0.0

1.3

—

170.78

—

Carcinoma in situ of oral cavity and pharynx

0.00

-0.00

0.0

1.1

—

156.94

—

Actinic reticuloid

0.00

-0.00

0.0

1.5

—

133.83

—

Carcinoma in situ of lip, oral cavity and pharynx

0.00

-0.00

0.0

1.2

—

349.29

—

Nutritional marasmus

0.00

-0.00

0.0

1.3

—

262.00

—

Enterobiasis

0.00

-0.00

0.0

1.2

—

263.60

—

Retrobulbar neuritis in diseases classified elsewhere

0.00

-0.00

0.0

1.3

—

203.50

—

Acute lymphocytic leukaemia

0.00

-0.00

0.0

1.2

—

553.67

—

Benign neoplasm: Lymph nodes

0.00

-0.00

0.0

1.3

—

200.83

—

Gender identity disorders

0.00

-0.00

0.0

1.3

—

589.22

—

Adenocarcinoma of small intestine

0.00

-0.00

0.0

1.3

—

218.67

—

Chloasma

0.00

-0.00

0.0

1.1

—

185.43

—

Benign neoplasm: Lacrimal gland and duct

0.00

-0.00

0.0

1.2

—

176.80

—

Corneal pigmentations and deposits

0.00

-0.00

0.0

1.3

—

220.07

—

Neuroendocrine tumor and carcinoma of stomach

0.00

-0.00

0.0

1.3

—

508.17

—

Other porphyria

0.00

-0.00

0.0

1.0

—

266.14

—

Relapsing fevers

0.00

-0.00

0.0

1.3

—

196.86

—

Relapsing fevers

0.00

-0.00

0.0

1.3

—

196.86

—

Congenital retinoschisis

0.00

-0.00

0.0

1.3

—

143.13

—

Accessory breast

0.00

-0.00

0.0

1.0

—

277.17

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

-0.00

0.0

1.2

—

188.92

—

Multiple system atrophy (rare forms of Parkinsonism)

0.00

-0.00

0.0

1.3

—

152.75

—

Acute lymphocytic leukaemia, including Hilmo

0.00

-0.00

0.0

1.2

—

553.67

—

Other hypertrichosis

0.00

-0.00

0.0

1.0

—

213.14

—

Plasmodium falciparum malaria

0.00

-0.00

0.0

1.2

—

253.00

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

0.00

-0.00

0.0

1.4

—

202.78

—

Benign neoplasm: Mediastinum

0.00

-0.00

0.0

1.3

—

135.20

—

Congenital hydrocephalus

0.00

-0.00

0.0

1.6

—

133.40

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.00

-0.00

0.0

1.2

—

206.40

—

Pediculosis and phthiriasis

0.00

-0.00

0.0

1.2

—

143.60

—

Other and unspecified syphilis

0.00

-0.00

0.0

1.3

—

201.67

—

Polyp of middle ear

0.00

-0.00

0.0

1.2

—

188.92

—

Alopecia universalis

0.00

-0.00

0.0

1.2

—

258.52

—

Disorders of other digestive organs in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

179.80

—

Maxillary prognathism

0.00

-0.00

0.0

1.1

—

531.43

—

Acne conglobata

0.00

-0.00

0.0

1.2

—

247.93

—

Onychogryphosis

0.00

-0.00

0.0

1.3

—

207.04

—

Mechanical strabismus

0.00

-0.00

0.0

1.0

—

252.95

—

Lichen planopilaris

0.00

-0.00

0.0

1.4

—

194.20

—

Diffuse (eosinophilic) fasciitis

0.00

-0.00

0.0

1.2

—

189.55

—

Other dermatomyositis

0.00

-0.00

0.0

1.1

—

204.07

—

Flexion deformity

0.00

-0.00

0.0

1.0

—

211.74

—

Other specified acquired deformities of limbs

0.00

-0.00

0.0

1.0

—

188.59

—

Progressive osseous muscle inflammation

0.00

-0.00

0.0

1.3

—

180.51

—

Small kidney of unknown cause

0.00

-0.00

0.0

1.3

—

227.59

—

Lens-induced iridocyclitis

0.00

-0.00

0.0

1.6

—

160.33

—

Traumatic spondylopathy

0.00

-0.00

0.0

1.5

—

136.21

—

Other and unspecified disorders of refraction

0.00

-0.00

0.0

1.3

—

233.17

—

Other obstructed labour

0.92

-0.00

1.9

1.3

168.89

436.80

u/l

—

Acute lymphocytic leukaemia, helper endpoint

0.00

-0.00

0.0

1.2

—

553.67

—

Other infestations

0.00

-0.00

0.0

1.3

—

153.60

—

Other helminthiases

0.00

-0.00

0.0

1.3

—

195.37

—

Impacted maxillary canine

0.00

-0.00

0.0

1.4

—

312.66

—

Yaws

0.00

-0.00

0.0

1.1

—

226.43

—

Congenital retinoschisis

0.00

-0.00

0.0

1.3

—

143.13

—

Neurofibromatosis, type 2

0.00

-0.00

0.0

1.2

—

266.80

—

Ototoxic hearing loss

0.00

-0.00

0.0

1.4

—

294.20

—

Toxic erythema

0.00

-0.00

0.0

1.4

—

201.12

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS